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GENERAL INTRODUCTION 
Int:roduct:ion 
Salmonella spp. are gram-negative, non-spore forming, 
facultative intracellular bacteria which belong to the family 
Enterobacteriaceae. Members of the genus Salmonella are 
extremely ubiquitous in nature, recovered from nearly all 
vertebrates as well as insects and are often referred to as 
universal pathogens. 
Salmonella are differentiated by biochemical reactivity 
and agglutination of the somatic (O) and flagellar (H) 
antigens. There are nearly 2300 serotypes of Salmonella which 
have been identified and each serotype is named utilizing 
genus, species nomenclature. 
Salmonella choleraesuis var. kunzendorf is the etiologic 
agent of swine paratyphoid and is the most common Salmonella 
serotype associated with swine. It has been estimated that 
swine salmonellosis is responsible for 28 million dollars in 
annual production losses in Iowa and 100 million in annual 
losses nationwide. 
However, if one recognizes that S. choleraesuis is the 
most frequent porcine isolate, but is rarely isolated from 
swine feeds or non-porcine Salmonella reservoirs, the 
conclusion must be drawn that the infected shedding pig is the 
source of new infections. There is a paucity of information 
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regarding characterization and identification of subclinical 
S. choleraesuis carrier swine. In order to control and reduce 
the presence of S. choleraesuis in the swine environment a 
better understanding of the carrier state is needed. 
The objectives of these investigations were to 1) 
determine if a S. choleraesuis carrier state model can be 
experimentally developed to study the affect of route of 
inoculation, the tissues of predilection and the immune 
response associated with the carrier state, 2) determine the 
affect of challenge dose on the immune response and 
persistence of S. choleraesuis and 3) study the natural 
transmission of S. choleraesuis to swine and assess the 
development of the carrier state and immune response. 
Dissertation organization 
The following dissertation consists of a general 
introduction, a literature review of salmonellosis with an 
emphasis on swine (to be submitted for publication), three 
manuscripts (submitted for publication), a general summary and 
acknowledgements. The doctor of philosophy candidate, Jeffrey 
T. Gray, is the senior author and principal investigator for 
these manuscripts-
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CHAPTER 1: SALMONELLOSIS IN SHINE; A REVIEW OF SIGNIFICANT 
AREAS AFFECTING THE CARRIER STATE. 
A manuscript in preparation for piiblication in 
the Compendium om Continuing Education for 
the Practicing Veterinarian 
Jeffrey T. Gray and Paula J. Fedorka-Cray 
THE ORGANISM 
Introduction 
Salmonella species (spp.) are facultatively anaerobic, 
non-spore forming. Gram-negative, facultative intracellular 
bacteria which belong to the family Enterobacteriaceae. The 
majority of Salmonella are motile, however nonmotile mutants 
may occur and one serotype, S. pullorum is always nonmotile 
(LeMinor 1984). Infection of animals with various species of 
Salmonella may or may not result in serious disease. It does, 
however, serve as a reservoir for potential transmission to 
humans. The interplay of Salmonella spp, with its host is 
varied and may include host specificity, inapparent 
infections, recovered carriers (subclinical carriers), 
enteritis, septicemia, abortion and combinations of disease 
syndromes. Salmonella spp. are zoonotic agents and are 
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readily transferred between animals, from animals to humans 
and between hiomans by direct or indirect means. 
Classification 
There is a variety of naming schemes associated with the 
genus Salmonella none of which are completely accepted by 
scientists in the field. DNA-DNA hybridization between 
salmonellas has indicated that there is not enough genetic 
variation to warrant species differentiation within the 
Salmonella genus (Hook 1990). Another study has divided the 
genus into three species, S. typhi, S. choleraesuis, and S. 
enteritidis (LeMinor 1984). In this schema S. typhi and S. 
choleraesuis each consist of a single serotype, while all 
other Salmonella are grouped under S. enteritidis. 
Currently, it is recognized that the genus Salmonella is 
divided into two species, S. enterica and S. bongori. 
Salmonella enterica is further subdivided into six subspecies; 
enterica, salmae, arizonae, diarzonae, indica and houtenae 
(Leminor and Popoff 1987; Reeves et al. 1989). Most 
Salmonella belong to S. enterica subsp. enterica. Members of 
this subspecies are given a name which is usually based on the 
geographic location where the serovar was first isolated. 
At the present time, there are approximately 2300 
serotypes of Salmonella which differ in antigenic structure, 
host adaptation and biochemical reactions. The most widely 
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used, and probably the most useful method of differentiating 
between Salmonella spp., is the Kauffman-White scheme (Hook 
1990). Serotypes are differentiated by exhaustive cross-
absorbsion and cross-reaction with antisera from the existing 
serotypes. The antigens responsible for differentiation are 
the somatic O antigens, as well as the flagellar H antigens 
and the Vi antigen (Falkow and Mekalanos 1990). Using this 
system Salmonella are named using a genus species format such 
as S. typhimurium. However, the species nomenclature clearly 
does not define a species but rather a serotype of Salmonella. 
PATHOGENESIS 
Infectious dose 
While ingestion of large numbers of Salmonella spp. may 
be required to initiate disease, disease is facilitated often 
by factors such as peristaltic impairment, interference with 
intestinal flora and elevation of gastric pH (Clarke and Gyles 
1993). The LDso for S. enteritidis in germ free mice has been 
shown to be only 3-5 organisms. However, the comparable value 
in conventional mice is 10® CFU (Collins and Carter 1978). 
These data have implicated normal intestinal flora as one 
protective factor from development of clinical salmonellosis. 
They may also serve to explain the greater susceptibility of 
the very young whose intestinal flora is not fully developed. 
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Most studies suggest Salmonella spp. gain access to the 
host by an oral route, pass through the stomach (during which 
time populations are greatly reduced), then colonize the 
intestine (Hale 1988). Intraluminal replication varies 
between serotypes. In swine, S. typhimurium replicates to 
much higher numbers intraluminally than S. choleraesuis which 
is inherently more invasive (Gianella et al. 1973; Reed et al 
1986). 
Adherence 
Attachment of Salmonella spp. to epithelial cells has 
been shown to be influenced by a nonfimbrial, mannose-
resistant adhesin which can mediate attachment of Salmonella 
spp. to mammalian tissue culture cells in vitro (Tavendale et 
al. 1983). Interestingly, many of the serotypes which are 
less invasive in humans have the mannose-resistant adhesin, 
whereas the more invasive ones, such as S. choleraesuis and S. 
typhi lack the adhesin (Clarke and Gyles 1993). This 
indicates that other virulence factors mediate disease 
outcome. Most serotypes of Salmonella posses mannose-
sensitive hemagglutinating pili (type 1) that bind to mannose 
derivatives on eukaryotic cells. However, the type 1 pili do 
not appear to play a significant role in adherence of the 
bacterium to the ileal mucosa (Finlay and Falkow 1988). 
7 
Invasion 
Much of the knowledge regarding the penetration of the 
intestine by Salmonella spp. is based on work by Takeuchi 
(1967). The bacteria enter enterocytes through the microvilli 
or via the tight junctions in between enterocytes then migrate 
via membrane-bound vesicles to the basal region of the cell. 
The Salmonella pass through the enterocytes to the lamina 
propria where they stimulate an inflammatory response and are 
phagocytized by neutrophils and macrophages (Takeuchi and 
Sprinz 1967). 
More recent studies have looked at the invasion process 
on a molecular basis and have divided this process into two 
stages. In the first stage, the bacteria adhere to an 
unidentified receptor on the epithelial cell surface and cause 
activation of a cascade of events on the cell surface which 
are mediated by the epidermal growth factor receptor (Galan et 
al. 1992b; Portnoy and Smith 1992). This series of events 
indicates that Salmonella invasion is dependant on both 
virulence factors of the pathogen and on the interaction of 
the host cell with the pathogen. In the second stage, 
invasion by Salmonella spp. induces a tyrosine phosphorylation 
of the epidermal growth factor receptor. It appears this 
phosphorylation induces increased intracellular calcium 
concentrations, microvilli depolarization, formation of 
extracellular blebs and internalization of the organism (Galan 
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et al. 1992a; Portnoy and Smith 1992). It has been shown that 
invasion is regulated by several global regulatory systems 
which are induced by environmental factors such as low oxygen 
concentration, temperature, and osmolarity (Galan and Curtiss 
1990; Lee and Falkow 1990; Jones et al. 1992). Other factors 
influencing invasion include chemotaxis, motility and 
flagellar orientation (Jones et al. 1992). However, plasmids, 
which have been shown to be critical for virulence, have no 
effect on invasion (Gulig and Curtiss 1987). 
Intracellular survival 
Once inside the cell. Salmonella spp. multiply in 
membrane-limited vacuoles with a generation time of about 50 
minutes. Salmonella spp. can survive within many cells; 
however, the most significant cell is probably the macrophage. 
Mutations which destroy this capacity include loss of LPS and 
certain auxotrophic and regulatory events. Cell wall 
composition has been shown to influence intracellular survival 
of S. choleraesuis (Griffith 1982). In the intracellular 
compartment the bacteria are protected from nonspecific 
defenses such as complement as well as antibody and some 
antibiotics (Falkow and Mekalanos 1990). 
Salmonella spp. synthesize over 30 proteins which are 
selectively induced during infection of macrophages. Two of 
these are heat shock proteins, GroEL and DnaK. Avirulent, 
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macrophage sensitive mutants have been shown to produce heat 
shock proteins but fail to synthesize different subsets of 
proteins normally induced within the macrophage. This 
indicates that these proteins are important for survival 
(Buchmeier and Heffron 1990). 
Intestinal inflammation, fluid production 
Salmonella spp. are known to produce cholera-like and 
shiga-like enterotoxins and these toxins may induce diarrhea 
independent of mucosal damage (Kinsey et al. 1976; Clarke and 
Gyles 1987). The Salmonella enterotoxin gene has been shown 
to be coded on the chromosome (Chopra et al. 1987). It must 
be noted however, that the production of toxins in vitro is 
somewhat obscure and not easily studied in the case of 
Salmonella. Therefore the overall importance of toxin 
production is not understood. In general, diarrhea observed 
with salmonellosis is believed to be primarily associated with 
the inflammatory response induced by Salmonella spp. (Gianella 
1979). This response stimulates local prostaglandin synthesis 
resulting in activation of the adenylate cyclase system 
increasing the secretion of fluid and electrolytes into the 
lumen (Falkow and Mekalanos 1990). The systemic signs and 
lesions relating to the septic form of this disease are 
commonly attributed to endotoxemia as a result of bacterial 
dissemination. 
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Cell free extracts of Salmonella have been shovm to be 
cytotoxic and inhibit protein synthesis in eukaryotic cells 
(Koo and Peterson 1982, Koo et al. 1984). These studies 
provide a molecular basis for the cellular damage caused by 
Salmonella cytotoxin during experimental salmonellosis (Koo et 
al. 1984). 
Extraintestinal infection 
The struggle between Salmonella spp. and the host is 
usually not localized in the intestine. This is especially 
true with S. choleraesuis infection (Cherubin et al. 1974; 
Wilcock 1979; Reed et al. 1986). Bacteria which may be 
intracellular or free in the mucosa and submucosa are 
transported by the lymphatics to the regional lymph nodes 
which contribute to the inflammatory response. From the lymph 
nodes. Salmonella spp. may travel via the efferent lymph 
vessels and drain into the circulatory system. They are 
filtered out of circulation via the reticuloendothelial 
system, usually by the spleen and liver. Release of endotoxin 
into the circulation may account for many of the systemic 
effects of disease including fever and vascular damage. 
Thrombosis of the small vessels may lead to ischemic necrosis 
of the extremities and tips of the ears, particularly with S. 
choleraesuis infection in swine. Failure to contain the 
infection will result in septicemia resulting in pneumonia, 
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meningitis and septic arthritis (Wray and Sojka 1977). 
Upper respiratory infection 
It has suggested that infection of the upper respiratory 
tract may influence the outcome of infection. Aerosol 
experiments in chickens and mice have shown that infections 
with Salmonella spp. can be achieved more regularly via the 
lungs than by oral inoculation (Clemmer et al. 1960; Darlow et 
al. 1961). 
Pneumonia associated with S. choleraesuis infection has 
been previously described (Baskerville and Dow 1973) and a 
recent increase in S. choleraesuis associated pneumonia has 
been reported (Turk et al. 1992). It is unclear whether this 
predilection for the lung is due solely to the pathogen, poor 
ventilation in large confinement buildings or some combination 
of these and other factors. Experimental infection models 
have not provided good answers because positive lung samples 
have been regarded as an artifact of intranasal or per os 
inoculation. However, Fedorka-Cray et al. (1995) has 
demonstrated that the lung is a primary site of colonization 
following intranasal inoculation of esophagotomized pigs. 
Additionally, Gray et al. (1995c) has also demonstrated that 
the lung is colonized in swine that are naturally exposed to 
pigs infected with S. choleraesuis. These data illustrate 
that lung colonization is not an artifact of experimental 
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inoculation. 
Swine have a large number of alveolar macrophages in the 
lung (Winkler and Cheville 1987). Fedorka-Cray et al. (1995) 
hypothesized that swine alveolar macrophages may have an 
impaired ability to contain Salmonella spp. within the early 
hours after infection. However, once uptake has occurred, the 
alveolar macrophages may act as a vehicle for dissemination of 
Salmonella spp. (Fedorka-Cray et al. 1995). 
Virulence factors 
Many potential virulence factors have been identified for 
Salmonella spp. but few have been tested critically for their 
contribution to virulence. It has been estimated that 
Salmonella spp. posses over 200 virulence factors, only a 
fraction of which have been characterized (Curtiss III 1994). 
Many studies have relied on in vitro data to draw their 
conclusions. This makes it difficult to develop meaningful 
extrapolations for human and animal disease. In addition many 
studies utilize mice as a model for disease and these results 
often cannot be repeated in other hosts. 
Several serovars have been shown to produce enterotoxins 
specifically cholera-like toxin (Prasad et al. 1990, 1992). 
Very little is known about this toxin as it relates to the 
pathogenesis of Salmonella spp. If it acts similarly to 
cholera toxin, the B subunit of the protein will bind to the 
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Gki ganglioside on the membrane of intestinal epithelial cells 
after which the A subunit is internalized causing activation 
of cAMP and prostaglandin synthesis. These changes would 
result in fluid and electrolyte secretion (Falkow and 
Mekalanos 1990). 
A common feature of Salmonella spp. induced enteritis is 
severe damage to intestinal epithelial cells likely the result 
of a cytotoxin. At least three cytotoxins have been 
identified. A wide variety of serovars posses a heat-labile 
cytotoxin described by Ashkenazi et al. (1988). Another 
cytotoxin is a low molecular weight, membrane associated toxin 
which has not been characterized (Reitmeyer et al. 1986). A 
third toxin, described by Libby et al. (1990), appears to be 
present in nearly all Salmonella spp., Shigella and 
enteroinvasive E. coli. This cloned protein is a 26 kDa cell-
associated hemolysin and its role in virulence is under study. 
The LPS of Salmonella spp. is a major determinant of host 
specificity and virulence. The intact LPS affords resistance 
to phagocytosis and killing by macrophages and complement-
mediated killing (Saxen et al. 1987; Robbins et al. 1992). In 
addition it has been shown that LPS is a major contributor to 
survival of Salmonella spp. in the intestinal tract (Nnalue 
and Lindberg 1990). The LPS component of Salmonella spp. also 
contributes to vascular damage and thrombosis. Endotoxic 
properties result in fever, disseminated intravascular 
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coagulation, circulatory collapse and endotoxic shock 
associated with salmonellosis (Takeuchi and Sprinz 1967; 
Clarke 1985). 
Motility provided by flagella appears to be important for 
invasion for some, but not all, serotypes of Salmonella 
Regardless of the other contributions the flagella may make, 
their presence increases the probability that the organism 
will come in contact with an epithelial cell. It has been 
shown that strains with polar rather than peritrichous 
flagella have increased ability to come in contact with, and 
potentially invade, epithelial cells (Jones et al. 1992). 
A siderophore has been identified in S. typhimurium 
called enterobactin (Benjamin et al. 1985). This protein does 
not appear to be necessary for full virulence and the 
importance of the protein may be relative to the amount of 
extracellular growth which occurs. Interestingly, pigs 
infected with S. choleraesuis have a reduction in serum iron, 
total-iron binding capacity and transferrin. The 
intracellular environment is low in iron and it has been 
suggesting that S. choleraesuis has a nonsiderophore mechanism 
for scavenging iron (Clarke and Gyles 1993). 
Finally, heat shock proteins have been shown to be 
produced by S. typhimurium inside murine macrophages. Mutants 
which are defective in this ability to produce these proteins 
are less virulent in mice and do not survive well in 
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macrophages (Falkow and Mekalanos 1990). 
DISEASE IN SWINE 
Associated serotypes 
Clinical swine salmonellosis can be separated into two 
syndromes. Salmonella typhiwurium is associated with 
enterocolitis, while S. choleraesuis is usually associated 
with septicemia. In the United States clinical swine 
salmonellosis is almost solely due to infection with S. 
typhimurium or S. choleraesuis. Clinical disease has also 
been associated with S. typhisuis. This serotype is difficult 
to isolate and because of this difficulty may be responsible 
for more outbreaks than it is directly associated with by 
culture (Wilcock and Schwartz 1992; Clock 1994). In addition, 
their have been reports of both S. dublin (Lawson and Dow 
1966) and S. enteritidis (Reynolds et al. 1967) causing 
disease in swine. In contrast, other countries see clinical 
disease from many serotypes and S. choleraesuis may or may not 
be one of them (Nielsen 1995). 
The vast majority of S. choleraesuis outbreaks in swine 
are due to the HaS producing variant kunzendorf (Wilcock and 
Schwartz 1992). However, the non-HaS producing S. 
choleraesuis has been as high as number 2 in the top 10 most 
common Salmonella isolates from swine in a given year (Ferris 
and Thomas 1993). 
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Populations affected 
Intensely reared weaned pigs are most often affected by 
Salmonella infection. In general, S. typhimurium tends to 
cause disease in young pigs from six to twelve weeks of age. 
Disease from this serotype is rare in adult animals? however, 
infection is not. Salmonella choleraesuis causes disease among 
a wider range of ages. Mortality tends to be higher in 
younger rather than older pigs, while morbidity is often equal 
regardless of age. Disease from S. choleraesuis in the adult 
is not a common occurrence. However, if a susceptible 
population is exposed, the animals will be affected 
significantly (Wilcock and Schwartz 1992). It is not known 
how common subclinical infection is in the adult. Normally 
only moribund, suspect cases are cultured for S. choleraesuis. 
In suckling pigs disease is distinctly uncommon but infection 
is not (Gooch and Haddock 1969; Wilcock et al. 1976). The 
occurrence of salmonellosis in suckling pigs is rare, 
presumably because of lactogenic immunity, while neonatal 
swine are susceptible to oral challenge with salmonellae and 
develop disease similar to that observed in weaned pigs 
(Wilcock and Olander 1978). 
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Septicemia 
The septic form of porcine salmonellosis is usually 
caused by S. choleraesuis. Affected pigs are inappetent, 
lethargic and febrile with temperatures up to 107°F. 
Respiratory signs may consist of a shallow moist cough and 
diaphragmatic breathing. Clinical signs first appear after 
24-36 hours of infection (Reed et al. 1986). Often, producers 
will find the first evidence of disease as dead pigs with 
cyanotic extremities and abdomens. In most outbreaks, 
mortality is high and morbidity is variable but generally less 
than 10% (Reed et al. 1986; Wilcock and Schwartz 1992). 
Diarrhea is normally not a feature of S. choleraesuis 
infection until at least the fourth or fifth day of infection. 
It may last from five to seven days after onset if chronic 
reinfection is not occurring. 
Gross lesions include colitis, infarction of gastric 
mucosa, swollen mesenteric lymph nodes, splenomegaly, 
hepatomegaly and lung congestion. Random white foci of 
necrosis are often observed on the liver (Reed et al. 1986; 
Wilcock and Schwartz 1992). 
The microscopic lesion which is most often associated 
with S. choleraesuis in swine is the paratyphoid nodule. This 
lesion can be viewed in the liver as clusters of histiocytes 
amid foci of acute coagulative hepatocellular necrosis and 
corresponds to the white foci seen grossly (Lawson and Dow 
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1966). Other lesions may include fibrinoid thrombi in venules 
of gastric mucosa, cyanotic skin and glomerular capillaries. 
Swelling of histiocytes and epithelial cells typical of gram 
negative sepsis, as well as hyperplasia of reticular cells of 
the spleen and lymph nodes are often observed (Wilcock et al. 
1976). 
Enterocolitis 
Salmonella spp. enterocolitis in pigs is typically 
associated with S. typhimarium infection and occasionally with 
S. choleraesuls infection. In contrast to the septicemic 
disease, the initial sign of infection is often a watery 
yellow diarrhea. Infected pigs are inappetent, febrile and 
lethargic. Mortality is usually very low however morbidity 
can be very high within a few days after infection (Wilcock 
and Schwartz 1992). 
The major gross lesion at necropsy is focal or diffuse 
necrotic colitis and typhlitis. Mesenteric lymph nodes are 
greatly enlarged. Intestinal lesions develop as red, rough 
mucosal surfaces that may also have gray-yellow debris. Colon 
and cecal contents are bile stained and scant, often with 
black or sand-like gritty material on the surface. 
Intestinal necrosis may be seen as sharply delineated button 
ulcers often associated with resolving lesions (Wood and Rose 
1992, Wilcock and Olander 1978; Wilcock and Schwartz 1992). 
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In cases of S. typhimurium enterocolitis, the liver and spleen 
are not enlarged except by terminal congestion (Wilcock and 
Schwartz 1992). 
Histopathologic examination reveals necrosis of cryptic 
and surface enterocytes which may be local or diffuse. The 
lamina propria and submucosa contain macrophages and 
lymphocytes with neutrophils observed only in the very early 
stages of disease. It is not uncommon to see lymphoid atrophy 
or regenerative hyperplasia associated with this disease 
(Wilcock et al. 1976, Jubb et al. 1985, Reed 1986). 
EPIDEMIOLOGY 
General Introduction 
Members of the genus Salmonella are extremely ubiquitous 
in nature, recovered from nearly all vertebrates as well as 
insects and are often referred to as universal pathogens 
(Taylor and McCoy 1969; Falkow and Mekalanos 1990). Taken as 
a whole, it is useful to group Salmonella spp, into three 
groups on the basis of host-adapted preference. The first 
group are Salmonella serotypes highly adapted to humans. The 
prototype of this group is the typhoid bacillus, S. typhi. 
The second group are Salmonella serotypes highly adapted to 
specific hosts other than humans. Some examples of this group 
are S. pullorum or S, gallinarum which are adapted to avian 
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hosts or S. typhisuis and S. choleraesuis which are adapted to 
swine. In addition, S. abortusovis is a serotype highly 
adapted to sheep and is a major cause of abortion in ewes. 
Their are also serotypes such as S. dublin which is viewed 
primarily as a pathogen of cattle but is often found in other 
hosts (LeMinor 1984). However, some serotypes in this second 
group can cause severe disease in humans which may result in 
high mortality. This has been observed following infection by 
S. choleraesuis (Cherubin 1980). The third group of 
salmonellae would be those with a broad host range. Most 
Salmonella spp. belong to this category and S. typhimurium is 
the best known serotype of this group. It is the serotype 
most frequently associated with gastroenteritis worldwide 
(Falkow and Mekalanos 1990). 
Salmonella in pork products 
Wilcock and Schwartz (1992) consider the epidemiology of 
Salmonella in swine as two relatively separate problems: 1) 
The contamination of pork carcasses and retail products with 
Salmonella spp. and 2) salmonellosis as a disease of pigs. 
They also point out that failure of prevalence surveys to 
distinguish the two conditions has led to considerable 
confusion about the etiology and epidemiology of clinical 
salmonellosis in swine. It should be noted that infection of 
swine and swine products by a wide variety of serotypes is 
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coiainon, but clinical disease caused by serotypes other than S. 
typhimurium or S. choleraesuis is distinctly uncommon. 
Due to the potential threat of foodborne illness in 
humans resulting from consumption of contaminated pork, it is 
appropriate that we briefly consider this subject. The 
results of these studies will not be discussed in depth here. 
It is accepted that the infected pig leaving the farm is most 
often considered the original source of abattoir infections. 
Also of importance is that S. choleraesuis is rarely 
associated with contamination of carcasses and pork products. 
As mentioned earlier, S. choleraesuis is a host adapted 
serotype that rarely infects humans; however, in cases where 
it has infected humans, it presents a disease of grave 
consequence that is difficult to diagnose and treat (Cherubin 
1980). 
In contrast, the top 10 serotypes isolated from swine in 
1994 (Ferris and Thomas 1994) include at least 3 
(S.typhimurium, S. heidelberg, S. agona) of the top 10 
serotypes commonly associated with human disease (Bean and 
Griffin 1992). This indicates that serotypes which coxnmonly 
cause disease in humans may be closely associated with pork 
and pork products. 
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Distribution and prevalence 
Salmonellosis as a disease in swine occurs worldwide but 
varies markedly in estimated prevalence and mortality as there 
seems to be variation in prevalence between serotypes. Some 
of this variation can likely be explained by the virulence of 
the specific strains endemic to an area or from the genetic 
variation of breeding stock. Investigators have added to the 
confusion in this area. Often reviews report epidemiologic 
data from slaughterhouse or federal surveillance studies which 
are unsupported by clinical or pathologic criteria for 
salmonellosis (Wilcock and Schwartz 1990). There is also 
marked variation in the prevalence of Salmonella spp. 
responsible for disease production in data reported from 
diagnostic laboratories. There could be many explanations for 
this amount of variation. Of particular concern are 
variations in bacteriologic culture methods utilized to 
isolate the organism. Salmonella typhimurium is much less 
difficult to isolate than S. choleraesuis because it grows 
readily in all of the standard selective media used, whereas 
host adapted strains often require more specialized media 
(Ewing 1986). 
Overall, regardless of animal species, the number one 
Salmonella isolate is S. enteritidis. Ferris and Frerichs 
(1990) found that S. choleraesuis has been, and is currently, 
the second most frequently isolated Salmonella spp. from all 
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animal sources in the United States since 1979. The isolation 
rate was greater than 99% from swine when compared to all 
other animals. 
In the late eighties and early nineties, the reported 
isolations of salmonellosis due to S. choleraesuis were 
increasing. One laboratory reported 256 isolations in 1981 
with gradual increases to 788 in 1989. In 1989 S. 
choleraesuis was isolated from >95% of swine salmonellosis 
cases while S. typhimurium represented 4% of cases (Schwartz 
1990). Causes for the increase are \mknown. Recent reports 
indicate the trend may be declining (Ferris and Thomas 1994). 
Cost 
Owen (1990) estimated that the cost of salmonellosis as a 
disease to Iowa swine producers ranks second to swine 
dysentery caused by Serpulina hyodysenteriae. The National 
Animal Health Monitoring Survey estimated that swine 
salmonellosis is responsible for 28 million dollars in annual 
production losses in Iowa and 100 million in losses nationwide 
(Schwartz 1990). There are no estimates of costs associated 
with siabclinical infections of Salmonella in swine. 
Source of infection 
As previously noted. Salmonella is ubiquitous in nature. 
However, if one recognizes that S. choleraesuis is the most 
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frequent porcine isolate, but is rarely isolated from swine 
feeds or non-porcine salmonella reservoirs, the conclusion 
must be drawn that the infected shedding pig is the source of 
new infections (Wilcock and Schwartz 1992). It has been shown 
that experimentally challenged pigs can shed up to lOVg of S, 
choleraesuis (Smith and Jones 1967) and 10'/g of S. 
typhimurium (Gutzmann et al. 1976) in the feces. The 
challenge inocula used in these studies were as high as 10^^ 
cfu which seems to be an inoculum unlikely found in the 
environment. The minimum infective dose for either S. 
choleraesuis or S. typhimurium has not been established. 
Often investigators infect swine with doses of lO'-lO" cfu. 
Fedorka-Cray et al. (1994) demonstrated that pigs infected 
with 10* CFU of S. typhimurium will develop a short term 
carrier state. Gray et al. (1995b) demonstrated that 
experimental infection of pigs with 10® CFU of S. choleraesuis 
will be cleared with no apparent shedding or clinical signs. 
In contrast, a dose of 10® CFU results in persistent infection 
for at least 9 weeks. 
Natural transmission studies with S. typhimurium in swine 
have indicated that subclinical carriers develop when naive 
swine are exposed to a population of swine shedding <10' CFU 
(Fedorka-Cray et al. 1994). Gray et al. (1995c) demonstrated 
that natural exposure of Salmonella-free swine to a population 
shedding 10® CFU S. choleraesuis/q of feces will result in a 
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severe clinical outbreak with some of the population carrying 
the organism for at least 12 weeks. In comparison to 
experimental models, the naturally exposed swine would have 
needed to ingest between 250 g (10® CFU dose) and 25000 g (10® 
CFU dose) of feces each to manifest the severe clinical signs 
observed in this experiment. This amount of coprophagia is 
unlikely. These data suggest that during natural 
transmission, the infectious dose of S. choleraesuis is much 
lower than experimental models have previously described. 
Swine may also be exposed to a large dose of S. choleraesuis 
by a mechanism other than fecal oral transmission. 
CARRIER STATE AND SHEDDING 
Species other than, swine 
Although Salmonella spp. may survive for long periods in 
the environment, it is widely believed that the carrier animal 
is the major source of infections for both animals and humans 
(Wray and Sojka 1977). 
The carrier state is defined as the absence of evidence 
of disease in animals that are able to transmit infection to 
susceptible individuals (Thrusfeild 1986). Carrier animals 
develop as a result of the interaction of several factors 
including the serotype of Salmonella, age of the animal, and 
number of bacteria ingested. Young cattle often shed 
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Salmonella only during convalescence, whereas adults are more 
likely to become chronic shedders. In addition a low dose 
which is insufficient to cause disease may result in a carrier 
state (Wray and Sojka 1977). 
In cattle various types of carrier states have been 
identified (Wray and Sojka 1977). The active carrier state 
may follow recovery from clinical disease and cattle may 
excrete Salmonella spp. for months or years in the milk and/ 
or the feces. The active carrier state often persists in the 
presence of high serum antibody titers to Salmonella O and H 
antigens. 
Passive carriers are described as cattle which ingest 
Salmonella spp. and pass the organisms through the intestine 
into the feces with little or no invasion of the mesenteric 
lymph nodes. These animals cease shedding Salmonella spp. 
shortly after they have been removed from the contaminated 
environment (Wray and Sojka 1977). Latent carriers are cattle 
which have deep tissue infection with Salmonella spp. but do 
not excrete the organism in their feces (Wray and Sojka 1977). 
Excretion may be reactivated by unknown mechanisms. 
Treatment of adult animals with antibiotics during the 
course of disease is ineffective in eliminating the carrier 
state in cattle infected with S. dublin (Wray and Sojka 1977). 
It is widely accepted that the antibiotic treatment of hiomans 
following infection with S. typhi (typhoid) is contraindicated 
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as it prolongs the carrier state (Askerkoff and Bennett 1969). 
Certain stress factors have been shown to promote 
activation or reactivation of clinical signs and shedding in 
Salmonella carrier cattle. These factors include, but are not 
limited to, transportation of animals, overcrowding, 
cortecosteroids, parturition and concurrent infection. 
Tannock and Smith (1971b) described the carriage of S. 
typhimurium in sheep for up to 6 weeks after intranasal 
inoculation. When the same inoculum was given orally by use 
of a gelatin capsule a prolonged carrier state was not 
observed. Tannock and Smith (1971a) also compared the effect 
of route of inoculation on the carrier state in mice. They 
concluded the upper respiratory tract provides a focus of 
infection. When the inoculation route is intranasal, a 
carrier state results for at least 6 weeks. As observed in 
sheep, the gastric route of inoculation did not result in 
development of a carrier state. 
Carrier state in swine 
After experimental challenge of swine with S. 
typhimurium, Salmonella could be isolated from the feces daily 
for the first 10 days and frequently over 4-5 months. Four to 
seven months post challenge carrier animals were necropsied 
and greater than 90% of the pigs were positive for S. 
typhimurium in the mesenteric lymph node, tonsil, cecum or 
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feces (Wilcock and Olander 1978; Wood et al. 1989). In an 
unrelated experiment it has been shovm that a sub-clinical, 
undetectable infection can progress to a high level of 
shedding after the occurrence of stressful events such as 
farrowing or transport to slaughter (Wilcock and Schwartz 
1992). 
In contrast to this minimal understanding of the carrier 
state of S, typhimurium in swine, the duration of shedding and 
the locations of organisms for S. choleraesuis in carrier 
swine has not been studied until recently. Gray et al. 
(1995a) has recently described the carrier state of S. 
choleraesuis in swine. These data demonstrate that a 
subclinical carrier state exists for at least 12 weeks after 
experimental challenge. The tissues in which S. choleraesuis 
can most commonly be found in carrier swine are the ileocolic 
junction, ileocolic lymph node, cecal contents, tonsil, lung 
and colon, regardless of route of inoculation. Swine can also 
shed S. choleraesuis in the feces sporadically throughout the 
12 week period (Gray et al. 1995a) A dose dependant affect on 
persistence of S. choleraesuis in swine has also been observed 
(Gray et al. 1995b). Lower challenge doses such as 10' CFU 
may be cleared by pigs. In contrast, a moderate dose (10® 
CFU) may result in persistent infection for at least 9 weeks. 
High challenge doses (10' CFU) have been shown to result in 
long term carriers which may be related to an observed 
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lymphocyte immunosuppression. 
Recent experiments have indicated that S. choleraesuis 
which have been shed from infected swine can survive for at 
least 3 months in a wet fecal slurry and at least 6 months in 
dry, desiccated feces (Gray et al. 1995d). This indicates the 
importance of decontamination of the environment when 
reduction of Salmonella spp. is a goal. 
The influence of antibiotics on the frequency and 
duration of shedding of Salmonella in swine is not well 
understood. However, it is known that antibiotics do not 
affect the magnitude or intensity of shedding of S. 
typhimurium in swine (DeGeeter et al. 1976; Jacks et al. 
1988). Conversely, it has been shown that antibiotics may 
reduce the magnitude and duration of shedding of S. 
choleraesuis (Jacks et al. 1981). 
IMMUNITY AND VACCINATION 
Introduction 
There is continual debate over the importance of the 
humoral versus the cell-mediated immune response following 
Salmonella infections. This controversy stems from the 
pathogen's ability to reside successfully in both an 
intracellular and extracellular environment. Taken as a 
whole, these data suggest that both humoral and the cell-
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mediated response are important in resistance to Salmonella 
spp. infection. At the present time, there is a lack of 
information regarding the immune response in swine following 
Salmonella spp. infection. 
Humoral immunity 
Antibodies against Salmonella are common in sera 
following exposure to the pathogen. Passive transfer of 
antibodies against Salmonella spp. to offspring is observed 
(Royal 1968). Antibody can provide protection through 
opsonization of the pathogen, neutralization of toxins and 
initiation antibody dependent cell-mediated cytotoxicity. 
Many antigens from Salmonella have been shown to induce 
antibodies including LPS (Jimenez-Lucho and Leive 1990), 
proteins (Foulaki et al. 1989; Saxen et al. 1986; Udhayakumar 
and Muthukkaruppan 1987) and ribosomal fractions (Eisenstein 
1975). 
The importance of humoral immunity in protection from 
Salmonella infection is discussed by Eisenstein and Sultzer 
(1983). The experiments conducted in mice show increased host 
survival following challenge, increased duration of survival 
and passive protection against homologous strain challenge. 
Evidence suggests that specific antibodies in the colostrum of 
cows vaccinated with Salmonella may interact with organisms in 
the lumen of the gut of calves and influence the outcome of 
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infection (Royal 1968). 
Natural and antibody-dependent antibacterial mechanisms 
may be important in defense against Salmonella spp., 
particularly in the gastrointestinal tract. Secretory IgA is 
also found in the intestine of animals that have recovered 
from disease or that have been vaccinated orally (Clarice and 
Gyles 1994; Stabel 1993). Intestinal antibodies constitute 
the first line of specific immune defense to organisms which 
enter the gastrointestinal system. 
The amount of specific antibody in serum has not been 
shown to correlate with protection against experimental 
challenge of calves vaccinated with either a live attenuated 
mutant or heat-killed preparations of Salmonella spp, (Habasha 
1981; Lindberg and Robertsson 1983). In addition, not all 
animals which are infected or immunized with Salmonella 
develop titers to the organism even though they show increased 
survival from sxabsequent challenge (Clarke and Gyles 1994). 
Recently, antibody titers to nontyphoidal Salmonella 0-antigen 
have been suggested to confer protection against challenge 
(Robbins et al. 1992). 
Cell-mediated Immunity 
Salmonella is a facultative intracellular pathogen which 
can evade antibody in the intracellular environment. This 
suggests that a strong cellular response is needed for 
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pathogen elimination (Sell 1987). Infection with Salmonella 
has been shown to effectively induce cell-mediated immunity 
(Hanna et al. 1979a; Hanna et al. 1979b; Hassan and Curtiss 
III 1990; Jones et al. 1991). Transfer of sensitized T cells 
confers protection, whereas transfer of macrophages and B 
cells are not protective in the absence of T cells. Delayed-
type hypersensitivity develops in animals with natural and 
experimental salmonellosis (Robertsson et al. 1982a,b; 
Lindberg and Robertsson 1983). 
Generally, the cell-mediated immune response correlates 
well with protection in calves and mice immunized with live 
attenuated vaccines and subsequently challenged with large 
numbers of Salmonella spp. (Habasha 1981; Lindberg and 
Robertsson 1983; Eisenstein and Sultzer 1983). Cross-
protection has been demonstrated for S. typhimurium and S. 
dublin and may be attributed to shared 0-antigenic components 
and porin antigens (Habasha 1981; Lindberg and Robertsson 
1983). 
Interestingly, investigators have demonstrated that live 
vaccines were superior to killed bacteria in providing 
increased host survival which was facilitated by elimination 
of the organism from the spleen and liver (Collins 1974; 
Eisenstein and Sultzer 1983). Using a mouse model of typhoid 
fever the immunity induced by an aroA mutant of S. typhimurium 
was attributed to natural killer cell activity that was 
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observed in the early stages of disease. It was suggested 
that these cells may also contribute to host defense in the 
later stages of disease (Schafer and Eisenstein 1992). 
Mucosal Immunity 
Mucosal surfaces are the major sites in the body in which 
antigens are encountered. Throughout life, they are 
continuously bombarded by antigens, whether they are ingested 
food particles, microbes such as Salmonella, toxins, 
parasites, or allergens. Most infectious diseases develop on 
mucosal surfaces and in many the organism is limited to these 
sites. To combat this constant threat, vertebrates have 
developed a complex mucosal immune system that undertakes the 
task of limiting infections without interfering with the 
function of the fragile mucosal tissue (Klein 1989). 
The major humoral immune factor at these sites is locally 
produced secretory IgA antibody (Mestecky 1987). It has been 
estimated that 65 to 90% of immunoglobulin-producing cells 
produce IgA and 75% of the total immunoglobulin produced in 
humans is IgA (Michalek et al. 1995). 
An antigen that has come in contact with the mucosal 
surface must cross the epithelium to reach the lymphoid tissue 
in the lamina propria. On some mucosal surfaces, this 
crossing is affected by specialized cells overlying the 
lymphoid follicles (Michalek et al. 1995). In the intestine. 
34 
and probably also in the respiratory system, crossing the 
epithelixim is regulated by M cells. On the side opposite the 
luminal surface, lymphocytes attach themselves closely to the 
M cells. The M cells bind antigen on the luminal side, 
endocytose it and then exocytose the antigen to the 
lymphocytes on the opposite side. The M cells differentially 
bind antigens excluding commensal organisms and food antigens. 
Some invasive pathogens such as Salmonella spp. can use this 
transport mechanism to their advantage which results in access 
to macrophages and lymphocytes in which they can survive 
(Klein 1989). 
The M cells transport material in both directions. 
Lymphocytes, for example, have been seen moving through M 
cells by diapedesis and then entering the lumen of the gut. 
It has been hypothesized that most of the lymphocytes found on 
the luminal surface of the gut mucosa may have reached their 
destination by this manner (Klein 1989). This may be the 
mechanism by which swine challenged with S. typhimurium by 
mechanisms completely excluding oral gastric exposure are 
observed to have S. typhimurium positive intestinal tissues 
after only a few hours (Fedorka-Cray et al. 1995). It should 
be noted that the M cells take up antigens, but are unable to 
carry out the crucial presentation step which is required to 
initiate an immune response because they lack class II Mhc 
molecules and are unable to process the antigen for 
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presentation (Klein 1989). Therefore, the M cells must 
release the antigen to the mucosal associated lymphoid tissue 
(MALT) where presentation can take place. 
The collaboration of B lymphocytes with T helper 
lymphocytes (Th) may occur in the MALT or the draining lymph 
nodes. The B cells that encounter antigen and receive the 
necessary stimulation from Th cells leave the MALT without 
secreting antibody. As they mature and begin secreting 
antibody, they home back to the various MALTs where they 
settle back into the lamina propria (Bergmann 1986, Ogra and 
Karzon 1969). If the B cells encounter the same antigen again 
they begin to produce antibody resulting in a mucosal antibody 
response. What determines the B cells specificity to the MALT 
sites remains unclear. However, the homing of the B cells for 
the various MALTs is one characteristic of the mucosal immune 
system; another characteristic is the dominance of IgA-
producing B-cells over any other B lymphocytes although IgM, 
IgG and igE antibodies are also produced but in lesser amounts 
(Klein 1989). 
The cells found in the MALT include lymphocytes, natural 
killer cells, macrophages, mast cells and eosinophils. At 
least some of the lymphocytes, the intraepithelial 
lymphocytes, seem to be unique in the mucosae. Among this 
population about 15% are T lymphocytes. There is a dispute 
regarding the remaining 85% of intraepithelial lymphocytes. 
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The lamina propria contains true lymphocytes, both T and B 
cells, providing the necessary components for the initiation 
of an immune response in this area (Klein 1989). 
Mucosal antibody responses to Salmonella antigens have 
been shovm in swine after challenge (Gray et al 1995 a,c) and 
vaccination (Stabel et al. 1993). However, there have not 
been any studies providing a correlation of mucosal antibody 
response and increased resistance to salmonellosis in swine 
despite the critical importance of mucosal immunity. 
Vaccination 
It is generally accepted that live attenuated, orally-
administered Salmonella vaccines provide the best protection 
against Salmonella infection. The superior protection 
achieved in comparison to killed Salmonella bacterins and 
subunit vaccines is generally attributed to the ability of 
live vaccines to stimulate a more effective cell-mediated 
immune response. Oral administration allows the attenuated 
mutant to utilize natural routes of infection which 
facilitates the crucial step of antigen presentation to 
lymphocytes in the gut-associate lymphoid tissue. These 
events induce the production of secretory igA on mucosal 
surfaces (Clarke and Gyles 1994). 
Recently the development of specific nonreverting 
mutations to construct both homologous and heterologous 
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vaccine vehicles with multiple attenuating mutations has been 
achieved (Chatfield et al. 1992). 
A mutation in the galE region in S. typhi results in a 
deficiency in UDP-glucose-4-epimerase, the enzyme which 
converts UDP-glucose to UDP-galactose, an essential component 
of Salmonella spp, smooth LPS (Levine et al. 1989). In 
several large trials utilizing human subjects this mutant has 
appeared to be very efficacious. Because of this success, 
this mutation has been employed for many Salmonella serotypes 
including S. typhimurium (Nnalue and Lindberg 1990). However, 
the galE mutation was not successful when utilized in S. 
choleraesuis. The O antigen of Salmonella serogroups are the 
main component of host specificity and facilitate survival in 
the gastrointestinal tract and entry onto deeper tissues 
(Nnalue and Lindberg 1990). The galE mutation in S. 
choleraesuis does not reduce virulence in swine. This is due 
to the fact that galactose is missing from the oligosaccharide 
repeating unit of the O antigen side chain of S. choleraesuis 
(Nnalue and Stocker 1986). 
Another common attenuation involves the creation of 
auxotrophic mutants that require metabolites not available in 
animal tissues. Aromatic mutants, which have a complete block 
in the aromatic biosynthetic pathway have a requirement for 
aromatic metabolites such as para-aminobenzoate and 2,3-
dihydroxybenzoate. Oral vaccination with aroA, aroD mutants 
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in mice and calves has been effective in reducing disease and 
have been shown to be safe (Hook 1990; Robertson et al. 1983; 
Smith et al. 1984). 
Mutations in global regulatory pathways have also been a 
popular means of attenuation. Several studies have utilized 
strains with deletions (4) in the genes for adenylate cyclase 
(cya) and for cAMP-receptor protein (crp). Cyclic AMP and 
cAMP-receptor protein regulate at least 200 genes, many of 
which are required for breakdown of catabolites. Salmonella 
with deletion mutations in the cya,crp genes have been shown 
to be safe and effective in eliciting protective immunity in 
mice, chickens and pigs (Coe and Wood 1992; Curtiss and Kelly 
1987; Stabel et al. 1990; Stabel et al. 1991). A large study 
evaluating the safety and efficacy of a battery of S. 
choleraesuis Acya,Acrp isogenic mutants in mice indicates that 
several of these strains are protective and safe (Kelly et al. 
1992). 
Recently a S. choleraesuis strain which has been cured of 
the 50 kb virulence plasmid has been shown to safe and 
efficacious in swine (Kramer et al. 1991). The nonspecific 
mutation was obtained by repeated passage through porcine 
neutrophils. The plasmidless variant lacks the ability to 
invade Vero cell monolayers and porcine neutrophils as well as 
having increased resistance to killing by H2O2 and phagocytic 
killing by porcine neutrophils (Roof et al. 1992). 
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DETECTION OF SAUtONELLA 
Culture 
A great interest has developed in the animal production 
and food processing industries to create and evaluate new 
methods to detect, either directly or indirectly, the presence 
of Salmonella, spp.. Traditional culture methods are slow, 
cumbersome, expensive and require considerable manpower to 
complete. However, the culture of Salmonella is the standard 
by which all other methods are measured. Recovery of the 
organism is the only means by which definitive serotyping can 
be achieved. In addition, the isolation of the organism 
serves as an invaluable source of epidemiologic data which 
cannot be overlooked. 
It is always advisable to employ enrichment culture in 
the examination of various kinds of specimens for Salmonella 
spp.. The first step in the culture process should include an 
assessment of the competing flora and the physical state of 
the Salmonella in the sample. For example, for a pelleted 
feed sample which has been heated and dried in the processing 
step there will likely be relatively few competing flora and 
the Salmonella may be in a desiccated state. This warrants 
use of a non-selective nutrient broth (Ewing 1986). In 
contrast, fecal samples contain large numbers of competing 
flora and the Salmonella may be in any stage of growth 
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indicating the use of selective media for enrichment (Ewing 
1986). 
The media suggested for enrichment of Salmonella spp. in 
fecal specimens from carriers or suspected carriers are 
tetrathionate broth and selenite F broth (Ewing 1986). Many 
modifications have been made to these media and the 
application should be considered when choosing a medium for a 
specific purpose. Another useful medium for the enrichment of 
Salmonella spp. is Rappaport medium (Vassiliadis 1983), which 
utilizes malachite green and magnesium chloride as selective 
agents. However, this medium is easily overloaded when used 
as an initial enrichment and care must be exercised when 
developing an inoculation plan (1986). 
Smith (1952) found it absolutely necessary to utilize 
media other than tetrathionate broth and selenite F broth for 
the isolation of S. choleraesuis, both of which have been 
reported to be toxic for S. choleraesuis. The same caution is 
warranted when any host adapted serotype is suspected as many 
of the of the host adapted serotypes do not grow well in the 
highly selective Salmonella media, including S. typhi (LeMinor 
1984). It has been suggested that this may explain the 
infrequent isolation of S. choleraesuis in swine associated 
epidemiologic surveys (Ewing 1986). When possible, a 
combination of enrichment media should be employed and may 
include GN-Hajna broth and tetrathionate broth for the 
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isolation of host adapted serotypes as well as broad host 
range Salmonella spp. (Ewing 1986). 
Many plating media have been devised for the isolation 
and differentiation of Salmonella spp.. Plating media for use 
of isolation and differentiation of Salmonella spp. and other 
members of the genus Enterobacteriaceae may be divided into 
categories according to their selectivity. 
Differential media, with little selectivity for 
enterobacteriaceae, are used with some frequency. This group 
includes MacConkey agar on which the lactose negative 
Salmonella spp. appear as white colonies. All Salmonella spp. 
grow well on MacConkey agar (Ewing 1986). Moderately 
selective differential media includes Shigella-Salmonella agar 
and Hektoen Enteric (HE) agar. Hektoen Enteric agar is often 
considered a standard by which other Salmonella isolation 
media are measured (Dusch and Altwegg 1995). Again, all 
serotypes of Salmonella grow well on moderately selective 
differential media (Ewing 1986). 
The final category is the highly selective media which 
include brilliant green (BG) agar. The BG agars are very 
popular and can be considered as a one purpose medium for the 
isolation of Salmonella spp. Salmonella appear as smooth pink 
colonies on BG agar. Only a few other genus of bacteria can 
also appear as pink colonies similar to Salmonella and include 
pseudomonads, aeromonads, proteus and late lactose fermenting 
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E. coli. Although these agars are very useful in the 
isolation of Salmonella spp. some serotypes such as S. typhi 
do not grow well on these agars (Ewing 1986). 
A recent study compared HE agar, Rambach agar, SM-ID 
medium, xylose-lysine-Tergitol 4 agar (XLT4), novobiocin-
brilliant green-glycerol-lactose agar (NBGL) and modified 
semisolid Rappaport Vassiliadis medivim (MSRV) for the 
isolation of Salmonella spp. The test of these relatively new 
media found MSRV to be the most sensitive and specific but it 
was also the most difficult to use. The XLT4 plates were 
found to be as sensitive as HE with improved specificity. The 
other media did not perform as well (Dusch and Altwegg 1995). 
In all cases, pooled fecal samples are preferred over 
rectal swabs for the detection of Salmonella-carrier pigs 
(McCall et al. 1966). 
Enzyme linked immunosorbent assays 
Enzyme linked Immunosorbent Assays (ELISA) can be used to 
detect either the organism or a humoral immune response to the 
organism. Assays utilized to detect microorganisms in food 
and feed stuffs are gaining widespread use in the industry and 
are called antigen-capture ELISA. Whereas culture may take 3-
7 days to identify the organism, ELISA can detect the organism 
in a much shorter period of time, usually 1 day or less. 
However the reliability of some of these assays is 
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questionable. In general, the cleaner the sample the better 
the assay will perform. Usually feces does not test as well 
as food and feedstuffs. Feng (1992) listed and described 
several commercial rapid screening assays. Several antigen 
capture immunoassays have been utilized to detect Salmonella 
spp. in swine feces (Araj and Chugh 1987; Lambiri et al. 1990; 
van Poucke 1990). They have the same disadvantage of many 
ELISA tests in that they require 10*-10® CFU of Salmonella per 
ml to detect the organism (Dziezak 1987). In order to achieve 
these numbers, a time consuming and expensive concentration 
protocol or a lengthy pre-enrichment must be employed. Some 
investigators have had success utilizing rapid enrichment 
protocols to detect Salmonella spp. in swine feces 
(Cherrington and Huis in't Veld 1993a,b) 
The second use of ELISA is to detect animals which have 
been, or are currently, infected with Salmonella spp. This 
procedure is not new, and was first described by Carlsson et 
al. (1972) to detect antibodies specific for Salmonella LPS. 
Several studies have focused on this approach and have found 
that LPS antibody titer can be an important diagnostic tool 
for detection of Salmonella infected cattle (Smith et al. 
1989; Spier et al. 1990, 1991). 
The detection of antibodies to the O antigen of 
Salmonella has also been utilized successfully in swine 
(Nielsen et al. 1994). The mixed ELISA utilizes LPS produced 
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by the method of Westphal (1965) from either S. typhxmurium or 
S. choleraesuis. The majority of swine produce high titers to 
the O-antigen which are present whether or not shedding can be 
detected (Nielsen et al. 1994). The test can be utilized as a 
herd test but is not suited as an individual pig test. 
Unfortunately, experimetally and naturally infected swine 
have been shown to have a titer to LPS for at least 12 weeks 
after exposure to S. choleraesuis even after clearing the 
bacteria (Gray et al 1995a,c). This may result in a number of 
ELISA positive pigs which are no longer infected. It is 
unclear what effect vaccination has on the outcome of this 
assay. However, data indicates swine vaccinated with a 
commercially available modified live, plasmidless S. 
choleraesuis vaccine do not initiate a humoral immune response 
to S. choleraesuis antigens (Gray 1995e). This would suggest 
that swine vaccinated with this strain would appear as 
noninfected pigs on a diagnostic test. 
Another ELISA has been utilized to detect antibodies in 
Salmonella carrier swine employing a heat-extracted antigen 
(Kramer et al. 1994). The results from this study indicate 
that most pigs infected with S. typhinurium or S. choleraesuis 
have an antibody response to this antigen. This assay shows a 
correlation between higher magnitude of infectivity and a 
higher antibody response. 
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Polymerase chain reaction 
The extraordinary ability of the polymerase chain 
reaction (PGR) to exponentially replicate a target DNA 
sequence has made it a very powerful tool in the armamentarium 
of the diagnostician, epidemiologist and molecular biologist. 
This assay is based on the ability of target (organism) 
specific primers which, through complimentary DNA base-
pairing, anneal only to the target sequence. Thermostable DNA 
polymerase recognizes the template primer complex as a 
substrate which results in the simultaneous copying of both 
strands of the segment of DNA between the two annealed 
primers. The denaturation annealing and elongation steps take 
place in a cyclical fashion relying on the thermostability of 
the Tag-polymerase until the target sequence is amplified to 
detectable amounts (Ehrlich and Sirko 1994). 
The PCR assay has been used to identify Salmonella spp. 
in food and clinical samples (Araj and Das Chugh 1987; Rahn et 
al. 1992; Cohen N.D. et al. 1993). However, obstacles in the 
detection of organisms include the presence of substances 
inhibitory to PCR (Rossen et al. 1992; Wilde et al. 1990) and 
the inability to detect <10^ CFU per gram of sample without 
preenrichment (Ehrlich and Sirko 1994). Investigators have 
improved detection methods in PCR assays by combining it with 
immunomagnetic separation (Widjojoatmodjo et al 1991; 
Widjojoatmodjo et al. 1992) or by enrichment culture (Stone et 
al. 1994). 
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FUTURE DIRECTION 
Control of infection caused by serotypes other than S. 
choleraesuis is reliant on detecting the carrier pig, 
contaminated feed, or environmental sources of infection. 
Pigs are most likely to develop disease during periods of 
stress or when exposed to large numbers of salmonellae. The 
commingling and transport of weanling pigs from different 
sources to finishing farms enhances activation of latent 
carriers and assures exposure of stressed pigs to salmonellae 
(Allred 1972). 
Because S. choleraesuis is rarely, if ever, isolated from 
feed or feed ingredients the source of new infections would 
seem to be limited to carrier pigs and facilities previously 
contaminated with this serotype. It is not uncommon for 
outbreaks to occur in facilities with good sanitation 
suggesting that stress is a likely contributor to disease. 
Management practices which allow filling of grower and 
finisher rooms with single source and age pigs is beneficial. 
In addition, careful attention to good management practices 
such as proper animal density, dry comfortable pens, 
temperatures and adequate ventilation is critical (Wilcock and 
Schwartz 1992). 
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sporadic at best because of the unpredictable nature of fecal 
shedding. Even repeated negative cultures may not ensure that 
a herd or individual is not a potential source of infection. 
Use of Salmonella serology will determine if the animal has 
had previous exposure to salmonella but this has not been 
shown to have relevance to the carrier status or to the 
predictable probability of shedding of an individual animal 
(Nielsen et al. 1994; Kramer et al. 1994). However, 
serological testing of herds will provide valuable information 
regarding the ongoing prevalence of infection in the herd and 
allow a measurement regarding success of control strategies. 
Additionally, refusal to introduce animals which have a 
positive titer will eliminate the introduction of potential 
carriers, but may also eliminate a proportion of the 
population which is not infected (Wilcock and Schwartz 1992). 
In the United States monitoring herds for Salmonella spp. 
is not commonly practiced. However, other countries have had 
success with a monitoring and reduction program (Nielsen 
1995). Current interest suggests that monitoring herds for 
the presence of Salmonella spp. in the United States may 
become more common. In addition, there is a great deal of 
research being conducted regarding the analysis of hazards and 
the critical control points for reduction of Salmonella spp. 
in both the pre and post-harvest setting of swine production. 
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Abs'trac't 
This study was designed to investigate the carrier state 
of swine infected with Salmonella choleraesuis. Thirty-five 
pigs were divided into 3 groups. Groups 1 (n=15) and 2 (n=16) 
were challenged with 10® CFU of S. choleraesuis intranasally 
or by gastric route, respectively. Group 3 (n=4) served as 
uninoculated controls. Pigs were necropsied at 2, 4, 6, and 
12 weeks post inoculation. Clinical signs and microscopic 
lesions were more severe for group 1. Salmonella choleraesuis 
was recovered from a greater percentage of tissue samples for 
group 1 versus group 2 at 2, 4, and 6 weeks post inoculation. 
No differences were observed between groups at 12 weeks post 
inoculation. Regardless of route of inoculation, S. 
choleraesuis was most often recovered from the ileocolic 
junction, ileocolic lymph node, cecal contents, tonsil, lung 
and colon. Both groups shed S. choleraesuis in the feces 
sporadically throughout the 12 week period indicating that a 
carrier state is maintained for at least 12 weeks. However, 
group 1 shed higher numbers of S. choleraesuis initially. 
Serum IgG, IgM, and IgA antibody responses to S. choleraesuis 
lipopolysaccharide and heat extract antigens were observed for 
both groups. Higher serum IgG antibody titers to S. 
choleraesuis lipopolysaccharide were observed for group 2. 
Intestinal antibody responses for both groups included IgG and 
IgM responses but not an IgA response. Both routes of 
64 
inoculation stimulated peripheral blood B-cells while the 
intranasal route (group 1) was more effective at stimulating 
peripheral blood T-cells. The reduction in numbers of tissues 
infected and shedding observed for both groups coincided with 
the development of the host immune response. These data 
indicate that route of inoculation affects the development of 
humoral and cellular immunity, influences the amount of 
Salmonella shed into the environment and the distribution of 
Salmonella within tissue. 
Keywords; 
Salmonella choleraesuis, carrier state, swine. 
Introduction 
Salmonella choleraesuis is a host adapted, facultative 
intracellular pathogen that causes swine paratyphoid (Wilcock 
and Schwartz, 1992). It is the most frequent Salmonella 
serotype recovered from swine (Ferris and Miller, 1990) and 
was isolated from >95% of swine salmonellosis outbreaks in 
Iowa in 1989 (Schwartz, 1990). The National Animal Health 
Monitoring Survey estimated that swine salmonellosis is 
responsible for 28 million dollars in annual production losses 
in Iowa and 100 million in losses nationwide (Schwartz, 1990). 
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The carrier state of S. typhimurium in swine has been 
described (Wood et al., 1989, Wilcock and Olander, 1978). It 
has also been reported that a build up of Salmonella in the 
intestinal tracts of asymptomatic carrier swine can occur when 
they are subjected to stress suggesting that the asymptomatic 
carrier may be important in dissemination of Salmonella spp. 
in the environment (Hansen et al., 1964, Morgan et al., 1987, 
Williams, 1970). Although S, choleraesuis is the most 
frequent porcine isolate, it is rarely isolated from swine 
feeds or non-porcine Salmonella reservoirs. The source of S. 
choleraesuis seems to be limited to carrier pigs and 
facilities previously contaminated with this serotype (Wilcock 
and Schwartz, 1992). 
The carrier state of S. choleraesuis in swine, including 
the duration of shedding, location of organisms and immune 
status, has not been studied (Wilcock and Schwartz, 1992). 
Lack of information regarding the carrier state of S. 
choleraesuis in swine has hindered efforts to control the 
disease. 
Pneumonia caused by S. choleraesuis has been induced by 
intranasal inoculation (Baskerville and Dow, 1973) while oral 
inoculation of S. choleraesuis typically results in 
enterocolitis and septicemia (Lawson and Dow, 1965). 
Interestingly, the occurrence of pneumonia associated with S, 
choleraesuis infection in swine has increased in recent years 
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(Turk et al., 1992). No information is available regarding 
the effect of route of inoculation on development of the 
carrier state. 
The purpose of this study was to determine if the route 
of inoculation of swine with S. choleraesuis affects the 
induction of the carrier state and to evaluate the subsequent 
immune response. 
Materials and Methods 
Bacterial strains and challenge cultures. Wild type S. 
choleraesuis var. kunzendorf ;i;3246 (Kelly et al., 1992) was 
kindly provided by the laboratory of Roy Curtiss III, 
Washington University, St Louis, MO. A 12 week old pig was 
intranasally inoculated and the isolate was recovered from the 
ileocolic lymph node (ICLN), stored at -70'C in glycerol, and 
used as the challenge strain (3246pp). Challenge cultures 
were prepared by inoculating 10 ml of LB broth (Sambrook et 
al., 1989) with 100 111 of a -70 frozen stock culture, and 
incubating the culture overnight at 37°C on an orbital shaker 
at 150 rpm. A 1% inoculum was transferred into fresh LB broth 
and the culture was grown for 3.5 hours at 37°C and 220 rpm. 
The culture was centrifuged, the pellet was resuspended in 1/2 
volume of 0.01 M phosphate buffered saline (PBS, pH 7.0) and 
adjusted to a concentration of 1x10® CFU/ml (00^00=-123) in PBS. 
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Swine. Thirty-five 10 to 14 day old pigs were weaned, 
transported to isolation facilities at the National Animal 
Disease Center and raised in isolation (Fedorka-Cray and 
Harris, 1995). Tonsil (T), nasal (N) and rectal (R) swabs and 
fecal samples of piglets were repeatedly cultured to determine 
if Salmonella spp. were present through 6 weeks of age. Fecal 
samples from maternal sows were cultured pre- and post-
farrowing. 
Experimental design. At 6 weeks of age pigs were 
randomly divided into three groups. Each group was housed in 
separate isolation facilities and allowed to acclimate to the 
new environment for 1 week. Pigs were challenged at 7 weeks 
of age (day 0). Group 1 (n=15) was challenged intranasally 
with 1 ml (0.5 ml in each nostril dropwise on inspiration, 
alternating nostrils) of strain 3246pp at 1x10® CFU/ml in PBS. 
Group 2 (n=16) was challenged via gastric route using size 000 
gelatin capsules loaded with approximately 0.75 g of pelleted 
feed and 1 ml of strain 3246pp at 1x10' CFU/ml in PBS. The 
capsule was inserted past the tonsil into the proximal end of 
the esophagus by use of a Pet Piller" (H-Bar-S, Boerne, TX). 
Group 3 (n=4) served as uninoculated controls. 
Two mis of whole blood was collected in sodium heparin 
from all pigs on days 2,4,6 and 8 post-inoculation (PI) and 
cultured as described below. 
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Four pigs from group l and 2, and one pig from the 
control group were euthanized and necropsied at 2,4,6 and 12 
weeks PI, except that only 3 pigs from group l were necropsied 
at 12 weeks. Tissues were collected aseptically (sterile 
gloves and instruments for each tissue) for bacteriologic and 
histologic examination and included the turbinate (1 g; 
approximate weight), tonsil (4 g), thymus (3 g), mandibular 
lymph nodes (mandib-LN; 3 g), trachea (1 g), esophagus (1 g), 
lungs (8 g), bronchial lymph nodes (bronch-LN; 2 g), stomach 
wall (stom wall; 2 g), spleen (5 g), liver (5 g), middle ileum 
(ileum-mid; 4 g), ileocolic junction (ICJ; 6 g), ICLN (3 g), 
cecum (4 g), and colon (4 g); stomach contents (stom cont; 20 
g) and cecal contents (cec cont 25 g) were also collected and 
cultured. 
Histopathology. Tissues for microscopic examination were 
placed in 10% neutral-buffered formalin and fixed for 24 hours 
before processing. Tissues were embedded in paraffin wax, 
sectioned, stained with hematoxylin and eosin, and examined 
under a light microscope. 
Clinical signs. Rectal temperatures and clinical signs 
were taken 2 times daily until day 3 PI for pigs in all 
groups. Between days 4 and 14 PI, pigs were monitored once 
daily then once weekly after day 14 PI. 
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Rate of gain. Pigs were weighed on days -3, 4, 11, 21, 
25, 32, 39 and 46 PI. The daily rate of gain was calculated 
for- each group. 
Bacteriologic examinations. The schedule for 
bacteriologic sampling is summarized in Table 1. Fecal pools 
consisted of fresh 1-2 g samples of feces randomly collected 
from 10 different areas in a pen. Tissues (collected at 
necropsy) were minced using a sterile scalpel then 
homogenized. Fecal pools and tissues were homogenized in a 
stomacher 80 lab blender (Tekmar, Cincinnati, OH). All T, N, 
R swabs, fecal pools and tissues were incubated at 37°C in GN-
Hajna broth (GN; Difco, Detroit, MI) for 18 to 24 hours then 
streaked on brilliant green agar with sulfadiazine (80 /ig/ml; 
BGS; Difco, Detroit, MI). Additionally, at 18 to 24 hours 100 
/il of GN was transferred to Rappaport-Vassiliadis (RV) medium 
(Vassiliadis, 1983), incubated at 37°C for 18 hours, then 
streaked to BGS. All BGS plates were incubated 24 hours at 
37°C. Colonies having the appearance typical of Salmonella 
were picked and inoculated into triple sugar iron and lysine 
iron agar slants. Isolates having biochemical reactions 
typical of Salmonella were confirmed as group C by 
agglutination with Salmonella antiserum group C^O (Difco, 
Detroit, MI). Additionally, all isolates from the cecum, cec 
cont, ICJ, colon, and feces were confirmed to be urease and 
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indol negative. Representative isolates were serotyped at the 
National Veterinary Services Laboratory. 
Quantitative bacteriology was conducted on the tonsil, 
lung, ICLN, ICJ, and cec cont using the 5 tube most probable 
number (MPN) method (Wood and Rose, 1992) with GN, BGS and RV 
media as described above and are reported as the mean of the 
respective group for each necropsy day. 
Antigen preparation. Antigens used in ELISA assays were 
prepared as follows. Salmonella choleraesuis 3246pp 
lipopolysaccharide (LPS) antigen was prepared by the method of 
Westphal (1965) and lyophilized. Heat extract antigen (HE) 
from S. choleraesuis 3246pp was prepared by growing 1 liter of 
culture in super broth (Greenstein and Besmond, 1993) for 5 
hours at 37°C and 220 rpm. The culture was centrifuged (12000 
X g for 10 min). and resuspended in 20 ml sterile distilled 
HjO. The resuspended pellet was placed in an Omni Mixeir® (Omni 
International, Waterbury, CT) and homogenized on setting 6 for 
20 minutes. The homogenate was removed, placed in an 
Erlenmeyer flask and heated in a 65"C water bath for one hour. 
The cells were removed by centrifugation at 19000 x g for 6 
minutes and the supernatant was removed and filtered through a 
Millex-GV° 0.22 fim filter and stored at -20°C until use. 
Antigens used in lymphocyte blastogenesis assays were 
prepared as follows. Endotoxin from S. choleraesuis 3246pp 
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was prepared by the method of Morrison and Leive (1975). 
Salmonella choleraesuis 3246pp HE was prepared as described 
above, except that the homogenization step was omitted. 
Protein determination. Total protein {ng/vxl) was 
determined by the method of Bradford (1968) using bovine serum 
albumin as the standard. 
Intestinal antibody. Local intestinal antibody secretion 
was measured in intestinal wash collected as previously 
described (Dean, 1990). 
ELISA. Serum and intestinal antibody titers were 
determined by ELISA in 96-well Immulon 1 (Dynatech, Chantilly, 
VA.) plates incubated overnight at 4°C with 6 /ig/well of 
3246pp LPS antigen diluted in 0.01 M PBS (pH 7.2). Immulon 2 
plates (Dynatech, Chantilly, Va.) were coated with 6 /ig/well 
of 3246pp HE antigen diluted in 0.01 M PBS (pH 7.2). 
Serum samples were serially diluted two-fold in diluent 
buffer (PBS, pH 7.2, 0.04% Tween 20 (Bio-Rad, Richmond, CA), 
0.5% BSA). Samples were added to coated plates (50 jil/well) 
and incubated Ih at 37''C then washed 3x with wash buffer (WB; 
PBS, pH 7.2, 0.04% Tween 20). Immunoglobulin titers were 
determined by the addition of 50 /il/well peroxidase conjugated 
goat anti-swine IgM (mu specific) antibody diluted 1:1000 or 
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goat anti-swine IgG (gamma specific), peroxidase conjugated 
antibody diluted 1:1500 (Kirkegaard and Perry, Gaithersburg, 
MD). Plates were incubated Ih 37°C and washed 3x with WB. 
Enzyme-substrate reactions were initiated by the addition of 
25 Ml of TMB microwell substrate (1 component, Kirkegaard and 
Perry), as per manufacturers instructions. 
Serum IgA titers were determined by the method of Stabel 
et al. (1990) using the Immulon plates and antigens described 
above. For all assays, absorbance of all wells was measured 
at 410nm. Titers were determined by taking the reciprocal of 
the highest dilution having an optical density greater than 
the highest optical density of the day 0 serum sample. Titers 
are reported as the mean of the experimental value minus the 
mean of the control pig values. 
Intestinal antibody responses were determined by adding 
50 Hi of undiluted intestinal wash to antigen coated plates in 
triplicate. Plates were incubated overnight at 4°C. The 
assay was completed as described above. Optical densities are 
reported as the mean of the experimental value minus the mean 
of the uninoculated control value. 
Lymphocyte Blastogenesis Assay. Blastogenesis assays 
were performed at weeks 2, 4, 6 and 12 PI on necropsy pigs. 
Peripheral blood lymphocytes (PBL) were separated from 
heparinized blood by centrifugation over Ficoll-Paque 
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(Pharmacia, Upsala, Sweden) according to manufacturer's 
instructions. Cells were resuspended in 10 ml of Hank's 
balanced salt solution without calcium or magnesium (HBSS) and 
10 ml of lysing solution (0.013 M Na2HP04, pH 7.2), incubated 
for 40 seconds at room temperature and returned to isotonicity 
with 20 ml of restoring solution (0.1 M PBS, pH 7.4). Cells 
were centrifuged (450 x g), washed twice in HBSS and 
resuspended to 2.5 x 10® cells/ml in RPMI (RPMI 1640 with L-
Glutamine; Gibco, Gaithersburg, MD) containing 10% fetal 
bovine serum, 25 mM HEPES (Sigma) and 50 mg/ml gentamicin 
(Sigma). Microtiter plate wells contained cells (100 nl/vell 
in triplicate) and 100 fil of the either 3246pp endotoxin or 
3246pp HE antigen diluted to 50 ng/ml in RPMI media. Plates 
were incubated at 37 °C with 5% CO2 for 48 hours for B-cell 
proliferation assays or 5 days for T-cell proliferation 
assays. After inciabation plates were pulsed with 0.5 /iCi of 
^H-thymidine per well, incubated for 18 hours and harvested. 
Values are reported as the mean stimulation index (SI; defined 
as experimental values divided by negative control values) 
plus or minus the standard error of the mean for the 
necropsied pigs in each group. Wells containing media and 
cells alone served as negative controls and Concanavalin A 
(Sigma) at 10.0 nq/Tal served as a positive control. 
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Statistical analysis. Postmortem results of S. 
choleraesuis recovery between groups, between tissues and 
ELISA titers between groups were evaluated by the test. 
Results 
Clinical signs. A febrile response occurred in group 1 
which peaked at 41.3°C, 48 hours PI; group 2 peaked at 41°C, 
72 hours PI (data not shown). On days 2 through 7, all group 
1 and 2 pigs exhibited signs of depression and coughing, 
diaphragmatic breathing and chills were observed. However, 
clinical signs were more severe in group 1. Diarrhea (mild to 
severe) was also observed in 94% of group 1 pigs between days 
5 through 10 and in 25% of group 2 pigs. One group 1 pig 
developed a self-limiting rectal prolapse. No mortality 
occurred in either group. Clinical signs resolved for both 
groups by day 14 PI. 
Microscopic lesions. Group 1 pigs had more numerous and 
more severe microscopic lesions than group 2 pigs. Three 
group 1 pigs necropsied at 2 weeks PI had lesions in the 
cecum, liver, or lung. One of these pigs had marked focally-
extensive erosive typhlitis and mild multifocal acute 
necrotizing hepatitis; the second pig had moderate multifocal 
necrotizing hepatitis; the third pig had marked focally 
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extensive suppurative bronchopneumonia. At four weeks PI, 2 
pigs from group 1 had mild erosive typhlitis. Conversely, at 
2 weeks PI, only 1 pig in group 2 had microscopic lesions 
which consisted of marked erosive typhlitis and marked 
multifocal necrotizing hepatitis. Remaining pigs in the study 
lacked microscopic lesions. 
Weight gain. The average rate of gain for group 1 was 
negative for the first 11 days PI, whereas the control group 
and group 2 each gained at approximately 227 g/day. After day 
11 the average daily gain for all three groups was similar 
(approximately 386 g/day; data not shown). 
Antemortem bacteriologic results. All source sows and 
pigs were culture negative for Salmonella spp prior to 
challenge. Salmonella choleraesuis was recovered from 
antemortem blood culture from one group 1 pig on day 4 PI. 
The frequency of recovery of S. choleraesuis from fecal and T, 
N and R swab cultures is presented in Table 2. 
Excluding day 0, S. choleraesuis was recovered from 8 of 
15 (53%) fecal pools from group 1 versus 9 of 15 (60%) from 
group 2 (Table 2). Salmonella was not recovered from swabs or 
feces of group 3. 
The magnitude of fecal shedding was markedly higher for 
group 1 than group 2 (Fig. 1). Both groups shed low numbers 
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sporadically after 2 weeks PI. 
Postmortem bacteriologic examination. The frequency of 
recovery of S. choleraesuis is presented in Tables 3 and 4 for 
groups 1 and 2, respectively. Salmonella choleraesuis was 
recovered from more tissues in group 1 than group 2 at 2, 4 
and 6 weeks PI. The frequency of isolation was equal for the 
two groups at 12 weeks. 
Qualitative bacteriological data was combined for both 
groups by tissue for statistical analysis. These data 
indicate that S. choleraesuis is significantly more likely 
(p<.01) to be found in the ICJ, ICLN, cec cont, tonsil, lung, 
colon, liver and cecum than any other tissue (higher to lower 
order of likelihood, except that colon, liver and cecum are 
equal). Significant differences between group total positives 
(by necropsy) were not observed. 
The mean population (logio/g tissue) of S. choleraesuis 
was determined for the tonsil, lung, ICLN, ICJ and cec cont 
and is presented in Table 5. Salmonella choleraesuis was not 
detected in the tonsils of either group at 2 weeks however, 
tonsils were positive for both groups at 4 weeks. Tonsil 
populations increased markedly at 6 weeks PI (4 log^o CFU/g). 
Group 2 populations remained at this concentration until 12 
weeks PI while group 1 populations declined. Group 1 had 
higher populations of S. choleraesuis in the lung at 2 weeks 
PI, the ICJ at 2,4, and 6 weeks PI, the ICLN at 4 and 6 weeks 
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PI and the cec cont at 6 weeks PI. At 12 weeks PI a reversal 
was observed in that the cec cont population was higher in 
group 2 (Table 5.). 
Serum and intestinal antibody responses. The mean serum 
IgG titers to 3246pp LPS antigen are shown in Fig. 2a. The 
peak response for group 1 was 262 at 10 weeks PI. In 
contrast, the peak serum IgG titer to LPS for group 2 was 548, 
12 weeks PI. 
The IgM titers to 3246pp LPS were similar for both 
groups. The titers peaked at 112 and 85 within 3 weeks PI for 
groups 1 and 2, respectively then declined steadily (Fig. 2b). 
The serum IgA response to LPS was similar for both groups 
through 5 weeks PI (Fig. 2b). After 7 weeks PI the group 1 
IgA titer increased to 69 then declined steadily to 25 at 12 
weeks while the group 2 titer decreased to 0 at 7 weeks PI 
(Fig. 2b). 
Challenge with 3246pp resulted in relatively low titers 
to 3246pp HE antigen (Fig. 3). Serum IgG titers for groups 1 
and 2 peaked at 10 weeks PI at 58 and 83, respectively. The 
IgM titers to the HE antigen peaked 3 weeks PI for group 1 
(127) and 4 weeks PI for group 2 (73) then decreased sharply. 
No serum IgA titers were detected to the HE antigen. The 
serum antibody titers varied considerably between animals 
within a group. No statistically significant differences in 
78 
antibody titers were observed between groups. 
Intestinal antibody response to 3246pp LPS occurred in 
both groups within 2 weeks PI (Fig. 4a). The IgG response of 
group 1 increased throughout the 12 weeks experiment. In 
contrast, the group 2 IgG intestinal response to LPS decreased 
until 6 weeks then rose sharply at 12 weeks (0.48 OD). The 
intestinal IgM responses were higher for group 1 versus group 
2 through 6 weeks PI. However, at 12 weeks the group 2 
intestinal IgM response to LPS increased to 0.11 OD (Fig. 4a). 
No IgA response to 3246pp LPS was detected for either group. 
Intestinal antibody titers to S. choleraesuxs HE antigen 
were not as high as intestinal responses to LPS antigen (Fig. 
4b). However, IgG and IgM HE antigen trends for both groups 
were similar to the LPS response. No IgA response to 3246pp 
HE antigen was detected for either group. 
Blastogenic responses. Peripheral blood mononuclear 
cells from both group 1 and 2 developed an antigen-specific 
proliferative response to S. cboleraesuis endotoxin and HE 
antigens. Uptake of ^H-thymidine after 2 days in vitro 
incubation is indicative of B-lymphocyte activation (Fig. 5), 
whereas ^H-thymidine incorporation after 5 days is more 
indicative of T-lymphocyte activation (Fig. 6). Results 
indicated no significant difference in the proliferative 
response of lymphocytes group 1 and 2 swine following a 2 day 
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incubation with endotoxin or HE antigens. However, after a 5 
day incubation of lymphocytes with the same antigens, an 
increase in ^H-thymidine incorporation occurred at 2 weeks PI 
for group 2 and 4 weeks for group 1. 
Discussion 
Results of this study indicate that regardless of route 
of infection, S. choleraesuis can persist in the tonsil, ICLN, 
ICJ and colon and can be excreted in feces of experimentally 
infected pigs for at least 12 weeks PI. Therefore, upon 
infection with 10® organisms and after resolution of initial 
clinical signs, the bacteria persist at relatively low numbers 
in clinically normal pigs establishing a carrier state. 
Nnalue (1991) demonstrated that route of inoculation 
affects S. choleraesuis virulence in mice. In our study the 
intranasal (group 1) route of inoculation resulted in more 
lesions and more severe clinical disease suggesting that S. 
choleraesuis is more virulent in swine following exposure by 
this route. The pathology that was observed is consistent 
with acute disease caused by S. choleraesuis (Wilcock et al., 
1976). Studies by Fedorka-Cray and Stabel (1993) with S. 
typhimurium indicate that the intranasal route of inoculation 
results in a wider tissue distribution in swine. This result 
was attributed to the involvement of lymphatogenous (which 
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includes the nasopharyngeal lymphoid tissues and tonsil) and 
hematogenous exposure. 
Baskerville and Dow (1973) suggested that intensive 
rearing of pigs may contribute to pneumonia caused by 5. 
choleraesuis and that feeding habits of swine ensure that 
pathogens present on food and in the environment enter the 
nasal cavity. In this study group 1 had a greater magnitude 
and duration of fecal shedding when compared to group 2, 
resulting in more environmental contamination. In addition, a 
larger number of S. choleraesuis positive tissues were 
observed for group 1 versus group 2 for the first 6 weeks PI. 
These results suggest that respiratory exposure affects the 
pathogenesis and maintenance of S. choleraesuis in swine. 
There is a paucity of information regarding the magnitude 
and duration of fecal shedding of S. choleraesuis. One study 
indicated that 1.0® CFU of S. choleraesuis/q of feces is shed 
by pigs during acute infection following challenge with 10^° 
CFU of S. choleraesuis in sodium bicarbonate (Smith and Jones, 
1967). The challenge in this study was 10' CFU in PBS and 
marked clinical illness was observed. The magnitude of 
shedding was 10^ CFU/g which peaked between 72 hours and 3 
weeks PI. Beyond 3 weeks PI S. choleraesuis was only detected 
in the feces in low numbers. However, shedding was detected 
in both groups throughout the 12 week period. The T, N and R 
swab data and fecal cultures indicate that although these 
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samples may be sufficient to detect S. choleraesuis within a 
herd, they are not effective in detection of individual 
carrier animals. However, since S. choleraesuis is mainly 
found in swine and swine operations (Wilcock and Schwartz, 
1992) isolation from any sample suggests that an asymptomatic 
carrier is present, thereby increasing the likelihood for an 
outbreak within the herd. These data indicate that carrier 
animals shed low numbers of S. choleraesuis in feces and 
suggest that suspected shedders should be isolated from naive 
animals to control outbreaks involving S. choleraesuis in 
confinement units. 
Under experimental conditions, there appears to be no 
significant loss in rate of gain for the subclinical carrier 
when compared to the control. These data suggest that 
following recovery from acute illness the length of time to 
market weight should not be affected. However, chronic S. 
choleraesuis infection, concurrent disease and/or stress may 
compromise these results. 
Infection of swine with S. choleraesuis in the present 
study showed that the tissue distribution was similar to that 
reported for S. typhimurium (Wood et al., 1989) except that 
there was no predilection for 5. choleraesuis to colonize the 
tonsil during acute disease. As the subclinical infection 
progresses the numbers of S. choleraesuis in the tonsil 
increase markedly. The organism may persist in the tonsil of 
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intranasally infected pigs until 19 weeks post challenge (data 
not shown). This suggests that the tonsils are a critical 
site for maintenance of S. choleraesuis in a herd. Although 
S. choleraesuis is often associated with pneumonia in swine, 
we only recovered the pathogen from the lung up to 6 weeks PI. 
This suggests that recovery from the lung, but not the tonsil, 
is indicative of acute disease, while recovery from the tonsil 
is more likely to be indicative of a carrier animal. 
Additionally the data indicate that the tissues in which S. 
choleraesuis is most likely to be found at necropsy are the 
ICJ (68% recovery; groups combined) and ICLN (65% recovery; 
groups combined) suggesting that they should be included in 
slaughterhouse surveys and necropsies where S. choleraesuis is 
a potential isolate. 
The intestinal antibody responses observed were similar 
for both routes. Interestingly, no intestinal IgA response 
could be detected in contrast to the measurable serum IgA 
responses. However, a response may have occurred in the 
interval between necropsies or may have been too weak to 
detect in our assays. 
The serum IgG titers to 3246pp LPS continued to increase 
through 10 and 12 weeks for the group 1 and 2, respectively. 
The IgM titers peaked between 2 and 3 weeks PI, then dropped 
as the IgG titers increased, indicating the point when isotype 
switch likely occurred. The trends in isotype responses 
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observed in the serum were also evident in intestinal 
immunoglobulin responses. This sequence of antibody isotype 
titers is indicative of a classic humoral response to 
bacterial pathogens. 
It is also of interest that the increase in serum IgM 
titers at 2 weeks PI correlate with the marked increase in B-
cell activity at 2 weeks PI. The times associated with 
increased T-cell activity may be correlated with the isotype 
switch observed for the humoral response. 
Both routes of inoculation were equally effective at 
stimulating peripheral blood B-cells. However the intranasal 
route was more effective, although slower, at activating 
peripheral blood T-cells. 
Eisenstein and Sultzer (1983) proposed that adequate 
immunity to Salmonella spp. requires both humoral and cellular 
responses in the mouse model. This study indicates that swine 
can harbor S. choleraesuis for at least 12 weeks in the 
presence of relatively high IgG response to S. choleraesuis 
antigens. In general, we observed a combined humoral, mucosal 
and cellular immune response to S. choleraesuis antigens which 
coincided with the reduction in overall of S. choleraesuis 
infection. This suggests that adequate immunity to S. 
choleraesuis in swine requires both humoral and cellular 
immunity. 
In conclusion we have demonstrated that route of 
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inoculation impacts on the carrier animal. However, 
regardless of route of inoculation, a carrier state persists 
for at least 12 weeks following challenge with 10° CFU S. 
choleraesuis. 
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Figure Legends 
Figure l. Quantitative recovery of S. choleraesuis from fecal 
pools. Reported values are the MPN/g of feces for each group. 
Figure 2. Serum antibody response of swine following challenge 
with S. choleraesuis by either intranasal (group 1) or gastric 
(group 2) route to S. choleraesuis LPS antigen. Reported 
values are the mean ELISA titer minus the mean control titer 
of either IgG (panel a) or IgM and IgA (panel b) isotype 
specific assays. 
Figure 3. Serum antibody response of swine following challenge 
with S. choleraesuis by either intranasal (group 1) or gastric 
(group 2) route to S. choleraesuis HE antigen. Reported 
values are the mean ELISA titer minus the mean control titer 
of either IgG or IgM isotype specific assays. 
Figure 4. Intestinal antibody response of swine following 
challenge with S, choleraesuis by either intranasal (group 1) 
or gastric (group 2) route, to S. choleraesuis LPS (panel a) 
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or HE antigen (panel b). Reported values are the mean ELISA 
IgG or IgM specific OD minus the mean control OD collected 
from intestinal wash samples (undiluted). 
Figure 5. Two-day in vitro blastogenic response to S. 
choleraesuis endotoxin (shaded bars) and HE (hatched bars) 
antigen of peripheral blood lymphocytes from swine challenged 
with S. choleraesuis by either intranasal (group 1) or gastric 
(group 2) route and uninoculated control (group 3) swine. 
Figure 6. Five-day in vitro blastogenic response to S. 
choleraesuis endotoxin (shaded bars) and HE (hatched bars) 
antigen of peripheral blood lymphocytes from swine challenged 
with S. choleraesuis by either intranasal (group 1) or gastric 
(group 2) route and uninoculated control (group 3) swine. 
Table 1 - Bacteriologic sampling schedule 
Sample 
Day Week 
D1 D2 D3 1 2 3 4 5 6 7 8 9 10 11 12 
T,N,R' Swabs x*" X X X X X X X X X X X X X X 
Fecal Pool" X X X X X X X X X X X X X X X 
Necropsy"" X X X X 
a - T = tonsil, N = nasal, R = rectal; qualitative 
bacteriology. 
b - X designates sample taken. 
c - quantitative bacteriology. 
d - qualitative and quantitative bacteriology 
Table 2 - Number of samples positive for S. choleraesuis from 
tonsil, nasal, rectal swabs and fecal pools 
Day Week 
D1 D2 D3 1 2 3 4 5 6 7 8 9 10 11 12 
Group 1 Sample 15" 15 15 15 15 11 11 7 7 3 3 3 3 3 3 Total Pos. 
T o n s i l  2 1 0 0 0 0 0 1 0 1 1 1 1 1 2  1 1  
Nasal 011000000011110 6 
Rectal 5 1 6 9 00000001110 2 4  
F e c a l  + " +  +  +  - -  +  - -  -  +  +  -  +  -  8  
Group 2 16' 16 16 16 16 12 12 8 8 4 4 4 4 4 4 
Tonsil 823000012000011 18 
Nasal 102000000000000 3 
Rectal 8 1 0 0 00000010000 1 0  
F e c a l  + " +  +  - -  -  +  -  +  +  +  -  +  +  -  9  
a- Number of pigs swabbed at each time point. 
b- Results reported as S. choleraesuis present (+) or absent (-). 
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Table 3 - Recovery of S. choleraesuis from tissue of 15 
intranasally challenged pigs. 
Necropsy (week) 
Tissue 2 4 6 12 Percent 
Pos 
Turbinate 0 0 1 0 7% 
Tonsil 1 1 1 2 33% 
Thymus 0 0 0 0 0% 
Mandib-LN 1 0 0 0 7% 
Trachea 1 0 0 0 7% 
Esophagus 0 0 0 0 0% 
Lung 3 3 1 0 47% 
Bronch-LN 2 1 1 0 27% 
Stom wall 0 0 0 0 0% 
Stom cont 0 0 0 0 0% 
Spleen 2 2 1 0 33% 
Liver 3 2 1 0 40% 
Ileum-mid 1 0 2 0 20% 
ICJ 3 4 4 1 80% 
ICLN 4 4 2 0 68% 
Cecum 1 3 1 0 33% 
Cec Cont 2 3 2 2 60% 
Colon 1 3 2 1 47% 
Number Pos 25 26 19 6 
Collected 72 72 72 54 
Percent Pos 35% 36% 26% 11% 
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Table 4 - Recovery of S. choleraesuis from tissue of 16 
gastric (group 2) challenged pigs. 
Necropsy (week ^ 
Tissue 2 4 6 12 Percent 
Pos 
Turbinate 0 0 0 0 0% 
Tonsil 0 2 2 2 38% 
Thymus 0 0 0 0 0% 
Mandib-LN 0 0 1 1 13% 
Trachea 0 0 0 0 0% 
Esophagus 0 0 0 0 0% 
Lung 2 1 0 0 19% 
Bronch-LN 1 0 0 0 6% 
Stom wall 0 0 0 0 0% 
Stom cont 0 0 0 0 0% 
Spleen 1 0 0 0 6% 
Liver 2 1 0 0 19% 
Ileum-mid 1 3 0 0 25% 
ICJ 2 4 1 2 56% 
ICLN 4 3 2 1 63% 
Cecum 1 1 2 0 25% 
Cec Cont 1 3 1 2 44% 
Colon 0 0 2 0 13% 
Number Pos 
Collected 
15 
72 
18 
72 
11 
72 
8 
72 
Percent Pos 21% 25% 15% 11% 
Table 5 - Mean populations of S. choleraesuis recovered from 
tissues of pigs challenged by intranasal (group 1) or gastric 
(group 2) inoculation from 12 weeks PI. 
Log,oCFU/g tissue S. choleraesuis 
(n=4) 
Group 1 
Week Tonsil Lung ICJ ICLN Cec Cont 
2 P" 3.6 5.8 4.4 <0.1 
4 0.1 <0.1" 5.2 3.3 <0.1 
6 4.1 <0.1 3.8 3.4 3.2 
12 1.1 N° <0.1 N 0.1 
Group 2 
2 N 0.6 4.5 4.1 P 
4 0.7 P 4.2 0.4 0.1 
6 4.1 N 0.1 1.4 0.6 
12" 4^^ N 0^7 0^7 1.1 
a- positive by qualitative bacteriology only 
b- <l/g designation 
c- negative 
d- 12wk group 1 n=3 
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Footnotes 
" Difco, Detriot, MI 
Omni International, Waterbury, CT 
° Millipore, Bedford, MA 
Dynatech, Chantilly, VA 
° Sigma, St. Louis, MO 
' Bio-Rad, Richmond, CA 
^ Kirkegaard and Perry, Gaitherburg, MD 
''Pharmacia, Upsala, Sweden 
^ Gibco, Gaithersburg, MD 
Summary 
Experiments were conducted to establish the effect of 
dose on the persistence of S. choleraesuis infection in swine 
and to elucidate the immune response. Nineteen pigs were 
divided into three groups which were housed in separate 
isolation facilities. Groups 1 (n=5), 2 (n=5) and 3 (n=5) 
were inoculated intranasally with 10®, 10® and 10^ CFU of S. 
choleraesuis, respectively. Group 4 (n=4) served as 
uninoculated control pigs. Pigs were monitored for clinical 
signs, shedding patterns were determined, and serum was 
collected. Lymphocyte blastogenesis assays were conducted at 
0, 2, 4 and 6 weeks post inoculation (PI). Three pigs from 
groups 1, 2 and 3 and 1 pig from group 4, were necropsied 6 
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weeks PI. Two pigs from group 3 and 1 pig from group 4 were 
necropsied 10 weeks PI. All remaining pigs were necropsied 15 
weeks PI. Pigs in group 1 shed S. choleraesuis throughout the 
15 week experiment. A high percentage of the tissues sampled 
for were positive for S. choleraesuis at both 6 (89%) and 15 
(67%) weeks PI for group 1. The highest concentration of 
infection was found in the tonsils of group 1 at both 
necropsies. For group 2 pigs, S. choleraesuis was recovered 
from ileocolic lymph nodes at 6 weeks PI and shedding was 
observed through 9 weeks PI. Salmonella choleraesuis was not 
recovered after nine weeks PI from pigs in group 2. In 
contrast, S. choleraesuis was not recovered at any time point 
from tonsil, nasal and rectal swabs, fecal samples or necropsy 
tissues of group 3 or group 4 pigs. High serum IgG and IgM 
titers to S. choleraesuis lipopolysaccharide and soluble 
antigens were observed for group 1. Group 2 had moderate IgG 
and IgM titers to LPS and low titers to soluble antigens. 
Group 3 had mild serum IgG and IgM titers to S. choleraesuis 
antigens. Increased lymphocyte proliferation was observed for 
groups 1 and 2 in response to S. choleraesuis endotoxin- All 
four groups demonstrated a lymphocyte response to concanavalin 
A. However, a lower stimulation index was observed in group 1 
in response to S. choleraesuis endotoxin and concanavalin A 
which indicated that some form of lymphocyte immunosuppression 
occurred after the high dose challenge. These results 
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indicate that persistence of S. choleraesuis in host tissues 
is dose dependent. Short term persistence can occur after a 
dose as low as 10® CFU of S. choleraesuis (9 weeks). However 
with doses less than or equal to 10® the bacteria are 
eventually cleared. Higher doses of S. choleraesuis result in 
development of a long term carrier animal (at least 15 weeks) 
which may be related to observed lymphocyte immunosuppression. 
Introduction 
Salmonella choleraesuis is a host adapted, facultative 
intracellular pathogen that causes swine paratyphoid^. 
Salmonella choleraesuis is the most frequent Salmonella 
serotype recovered from swine^ and was isolated from >95% of 
swine salmonellosis outbreaks in Iowa in 1989=*. Although S. 
choleraesuis is the most frequent porcine isolate, it is 
rarely isolated from swine feeds or non-porcine Salmonella 
reservoirs. The source of S. choleraesuis appears to be 
limited to carrier pigs and facilities previously contaminated 
with this serotype^. It has also been reported that an 
increase in amounts of Salmonella in the intestinal tract of 
asymptomatic carrier swine can occur when they are subjected 
to stress*'®'®. Together these studies indicate that the 
persistently infected or asymptomatic carrier pig is critical 
in the maintenance, transmission, and dissemination of 
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Salmonella choleraesuis in the environment. Although the 
concept of an S. choleraesuis carrier state is not new, unlike 
S. typhimuriunT'^, specific details remain unknown. 
The minimum dose of S'. choleraesuis required to establish 
a persistent infection in swine has not been studied. There 
is also a lack of information regarding the minimum dose 
required to produce clinical disease. Only one report of 
moderate disease following a 10® inoculation of S. 
choleraesuis is available'. 
It has been shown that intranasal inoculation of S. 
choleraesuis in swine results in more severe clinical disease 
and dissemination of the organism to more tissues, as compared 
to a gastric challenge'-°'^^. Pneumonia caused by S. 
choleraesuis has been induced by intranasal inoculation". The 
occurrence of pneumonia associated with S. choleraesuis 
infection in swine has increased in recent years", implicating 
the respiratory tract as an important route of inoculation. 
We intranasally inoculated pigs with 3 different doses of 
S. choleraesuis and then monitored the magnitude and duration 
of shedding, distribution of organisms in the tissue and the 
immune response of swine over a 15 week period. 
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Materials and Methods 
Bacterial strains and challenge cultures. Wild type S, 
choleraesuis var. Kunzendorf ,3246" (3246), kindly provided by 
the laboratory of Roy Curtiss III, Washington University, St 
Louis, MO, was used as the challenge strain. 
Challenge cultures were prepared by inoculating 10 ml of 
LB broth with 100 liL of a -70"C frozen stock culture of 3246. 
The culture was grown overnight at 37°C on an orbital shaker 
at 150 rpm. A 1% inoculum was transferred into fresh LB broth 
and grown for 3.5 hours at 37°C and 220 rpm. The culture was 
centrifuged, the pellet was resuspended in 1/2 volume of 
phosphate buffered saline (PBS), and adjusted to an final 
concentration of 1x10' (ODgoo 0.832), 1x10® (1/1000 dilution of 
IxlO') or 1x10= (1/1000 dilution of 1x10®) CFU/ml in PBS. 
Final concentrations were confirmed by plate counts. 
Swine. Source sows were monitored prior to weaning for 
presence of Salmonella by bacteriology as described below. 
Nineteen 10 to 14 day old pigs were weaned and transported to 
isolation facilities at the National Animal Disease Center. 
Pigs were raised in isolation as previously described^®. Fecal 
pools and swabs were obtained from pigs prior to challenge at 
2, 4, 6 and 8 weeks of age and cultured to determine if 
Salmonella spp. were present. 
Ill 
Experimental design. At 7 weeks of age, 19 Salmonella 
culture negative pigs were randomly divided into four groups. 
Each group was housed in separate isolation facilities and 
allowed to acclimate to the new environment for 1 week. Pigs 
were challenged at 8 weeks of age (day 0). Group 1 (n=5) was 
challenged intranasally (INT) with 1 ml (0.5 ml in each 
nostril dropwise alternating nostrils) of 3246 at 1x10® 
CFU/ml. Groups 2 (n=5) and 3 (n=5) were challenged using the 
same procedures with 1 ml at 1x10® CFU/ml and 1x10^ CFU/ml, 
respectively. Group 4 (n=4) served as controls and were sham 
inoculated with sterile PBS using the same procedures 
described above. 
After inoculation, pigs were observed for clinical signs 
and rectal temperatures were taken daily for 14 days then 
weekly for 15 weeks. Antemortem bacteriologic examinations, 
which included separate tonsil (T), nasal (N), rectal (R) 
swabs and fecal pools, were performed on days 0,1,2,3,5,8 and 
weekly thereafter throughout the 15 week period. Fecal pools 
were obtained from the pens of each group by collecting fresh 
1-2 g samples of feces randomly from 10 different areas. 
Blood samples for serum collection were obtained on day 0, 
then weekly through 12 weeks and at week 15. 
Three pigs from groups 1, 2 and 3 and one control pig 
from group 4 were euthanized and necropsied at 6 weeks PI. 
Two pigs from group 3 and 1 control pig were euthanized and 
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necropsied at 10 weeks PI. At 15 weeks PI two pigs from 
groups 1 and 2 and 2 control pigs were euthanized and 
necropsied. Tissues were aseptically collected for 
bacteriologic examination. Tissues collected included the 
tonsil, lung, spleen, liver, ileal-colic junction (ICJ), 
ileal-colic lymph node (ICLN), cecum, cecal contents (Cec 
Cont), and colon. 
Bacteriologic examinations. All T,N,R swabs, fecal pools 
and tissues (collected at necropsy) were incubated at 37°C in 
GN-Hajna" (GN) broth for 18 to 24 hours then streaked on 
brilliant green agar with sulfadiazine" and 200 ng/vil 
streptomycin (BGSS). Additionally, at 18 to 24 hours 100 fiL 
was transferred to Rappaport-Vassiliadis (RV) medium", 
incubated at 37°C for 18 hours, then streaked to BGSS. All 
BGSS plates were incubated 24 hours at 37°C- Colonies having 
the appearance typical of Salmonella were picked and 
inoculated into triple sugar iron and lysine iron agar slants. 
Positive isolates were confirmed as group C by agglutination 
with Salmonella antiserum group CiO". Representative isolates 
were serotyped at the National Veterinary Services Laboratory, 
Ames, lA. Quantitative bacteriology was conducted using the 5 
tube most probable number (MPN) method" with GN, BGSS and RV 
medivuns as described above. Results are reported as the mean 
of the respective group for each necropsy day. 
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Erythrocyte sedimentation rate. Erythrocyte 
sedimentation rates (ESR) were determined as previously 
described^®. Blood samples for ESR's were collected in EDTA 
tubes on days 0, 2, 3, and 8 PI. 
Antigen preparation. Salmonella choleraesuis 3246 LPS 
antigen was prepared by the method of Westphal" and 
lyophilized. Soluble antigen from S. choleraesuis 3246 was 
prepared by growing 1 liter of culture in super broth (20 g 
tryptone, 10 g yeast extract, 20 g NaCl, pH 7.0) for 5 hours 
at 37°C and 220 rpm. The culture was centrifuged (12000 rpm 
for 10 min) and resuspended in 20 ml sterile distilled HaO. 
The resuspended pellet was placed in an Omni Mixer®'" and 
homogenized on setting 6 for 20 minutes. The homogenate was 
removed, placed in an Erlenmeyer flask and heated in a 65°C 
water bath for one hour. The cells were removed by 
centrifugation at 19000 rpm for 6 minutes and the supernatant 
was removed and filtered through a Millex-GV= 0.22 jum filter 
and stored at -20''C until use. 
Endotoxin from S. choleraesuis 3246 was prepared by the 
method of Morrison^® and lyophilized for use in the lymphocyte 
blastogenesis assays. 
114 
Protein determination. Total protein was determined by 
the method of Bradford®^ using bovine serum albumin as the 
standard. 
ELISA. Serum titers were determined by ELISA in 96-well 
Immulon" microtiter plates. Immulon 1 plates were coated with 
3 /ig per well of 3246 LPS antigen diluted in 0.01 M PBS (pH 
7.2) and Immulon 2 plates were coated with 3 /xg/well of 3246 
soluble antigen diluted in O.OIM PBS (pH 7.2). Following 
addition of antigen, plates were incubated overnight at 4°C 
then washed 3 times with PBS. Wells were blocked with 3% 
bovine serum albumin" (BSA) for thirty minutes at room 
temperature then washed 3 times with PBS. Plates were allowed 
to dry at room temperature and stored at 4°C for up to 48 
hours. 
Serum samples were diluted two-fold in diluent buffer 
(PBS, 0.04% Tween 20', 0.5% BSA) in 96-well microtiter 
dilution plates. Immunoglobulin titers for IgM and IgG in 
sera were determined by incubating diluted sera on the antigen 
coated plates for 1 hour at 37"c. Following incubation the 
plates were washed 6 times with wash buffer (WB; PBS, pH 7.2, 
Tween-20 0.04%). The washes were followed by the addition of 
50 ^tL/well goat anti-swine IgM (mu specific) peroxidase 
conjugated antibody' diluted 1/1000 or goat anti-swine IgG 
(gamma specific) peroxidase conjugated antibody' diluted 
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1/1500. All plates were incubated 1 hour 37"c. Plates were 
washed 6 times with WB before adding 25^L/well of TMB 
microwell substrate'' (1 component) per well. The reaction was 
stopped by the addition of 50 /iL/well of 1% sulfuric acid. 
All plates were read at 410nm on a 96 well microplate 
reader**. Titers were determined by taking the reciprocal of 
the highest dilution having an optical density greater than 
the highest optical density of the day 0 serum sample. Titers 
are reported as the mean of the experimental value minus the 
mean of the respective group 4 control value. 
Lymphocyte Blastogenesis Assay. Blastogenesis assays 
were performed on day 0 and at weeks 2, 4 and 6 PI on all 
pigs. Thirty ml of heparinized peripheral blood was collected 
from each pig and diluted with 30 ml of Hank's balanced salt 
solution without calcium or magnesium (HBSS). Thirty ml of 
diluted blood was then layered over 9 ml Ficoll-Paque" and 
centrifuged at 400 x g for 30 min. The mononuclear cell layer 
was removed and washed once with HBSS. Cells were resuspended 
in 10 ml of HBSS and 10 ml of lysing solution (0.013 M Na2HP04, 
pH 7.2), incubated for 40 seconds at room temperature and 
returned to isotonicity with 20 ml of restoring solution (0.1 
M PBS, pH 7.4). Cells were centrifuged (450 x g), washed 
twice in HBSS and resuspended to 2.5 x 10® cells/ml in RPMI 
1640 (containing 2 mM L-Glutamine)^, 10% fetal bovine serum. 
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25 mM HEPES" and 50 jug/ml gentamicin". Cells were dispensed 
into 96-well microtiter plates (100 ilL/vell in triplicate) 
containing 100 lil of 3246 endotoxin diluted to 50 /ig/ml in 
RPMI media. 
The plates were incubated at 37°C with 5% CO2 for 48 
hours. At the end of the incubation period, cells were pulsed 
with 0.5 fiCi of ^H-thymidine per well, incubated for 18 hours 
and harvested. Values are reported as the mean stimulation 
index (SI; defined as experimental values divided by negative 
control values) plus or minus the standard error of the mean 
for the necropsied pigs in each group. Negative control wells 
contained media and cells only. Positive control wells 
contained concanavalin A"(ConA) at 10.0 /ig/ml. 
Results 
Clinical response to exposure. Pigs in group 1 elicited 
a marked febrile response beginning 48 hours PI which lasted 
approximately 2 weeks. The response peaked on day 3 at 
41.2°C. Group 2 also elicited a mild febrile response 
beginning on day 3 PI which also lasted approximately 2 weeks 
(peak day 3; 40.8°C). Pigs in group 1 were slightly 
lethargic on day 2 PI. Lethargy and depression progressed 
from mild to severe on day 3 persisting until day 10 PI. Mild 
to severe diarrhea was observed in group 1 which lasted until 
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2 weeks PI. Mild depression and lethargy, but no diarrhea, 
was noted in pigs in group 2 between days 5 and 8. No febrile 
response or clinical signs were detected for groups 3 or 4. 
Erythrocyte sedimentation rates. Increased ESR values 
were observed for group 1 on day 2 (12.6 mm) and 3 (13.8 mm) 
PI. Group 2 had an increased ESR on day 3 (4.9 mm) PI (data 
not shown). The increased ESR values observed in groups 1 and 
2 returned to normal by 1 week PI. No increase in ESR values 
were observed for groups 3 and 4. 
Antemortem bacteriologic examination. Sows from which 
experimental pigs were obtained were culture negative for 
Salmonella spp. Prior to challenge all pigs were also culture 
negative for Salmonella spp. Group 4 control pigs remained 
free of Salmonella spp. throughout the experiment. Following 
challenge, S. choleraesuis was not recovered at any time on T, 
N, or R swabs or from fecal cultures of pigs in group 3. The 
frequency of recovery of S. choleraesuis on swabs and fecal 
cultures from groups 1 and 2 is presented in Table 1. 
Salmonella choleraesuis was recovered from both groups 1 and 2 
beginning on day 1 PI. At least 1 positive swab was obtained 
from group 1 throughout the 15 week period with the exception 
of week 13. Positive swabs were obtained from nearly all of 
the pigs in group 1 at each time point through 10 weeks PI. 
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Fecal pools of group 1 were positive through 8 weeks PI and at 
weeks 10, 11 and 15. 
Nearly all of the pigs in group 2 had positive swabs in 
the first week PI (4/5). The frequency of recovery of S. 
choleraesuis from swabs declined rapidly after 1 week PI. One 
positive rectal swab was obtained at 9 weeks PI from group 2 
(this was the last positive swab from the group). Sporadic 
recovery of S. choleraesuis from fecal pools of group 2 was 
observed until 9 weeks PI. 
The magnitude of fecal shedding for groups 1 and 2 is 
presented in figures la and lb, respectively. The magnitude 
of fecal shedding peaked for group 1 at 4.9x10^ CFU/g on day 5 
PI. A decline to 9.7x10^ CFU/g was observed at 3 weeks PI, 
followed by an increase to 7.9x10^ CFU/g at 5 weeks PI. After 
dropping to very low numbers (lO'^CFU/g), another smaller 
increase (4x10^ MPN/g) was observed at 10 weeks PI. The peak 
magnitude of shedding in group 2 was 4.2x10^ CFU/g on day 5 
PI, which decreased rapidly at 1 week PI to 10"^/g. Further 
decline to undetectable levels at 5 weeks PI was noted. A 
slight increase in fecal shedding was observed on weeks 7 and 
8 for group 2. 
Postmortem bacteriologic examination. The frequency of 
recovery of S. choleraesuis is presented in Table 2. The 
recovery from group 2 tissues was infrequent with only 1 
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positive ICLN found at 6 weeks PI. In contrast, group 1 only 
had 1 negative tissue (spleen) at 6 weeks PI. Two of the 3 
pigs had a positive tonsil, ICJ, ICLN, cecum, cec cont, and 
colon at 6 weeks PI. At 15 weeks PI, S. choleraesuis was 
found in the tonsil, cecum, cec cont, and colon of both pigs 
necropsied. One ICJ and ICLN were also positive. Salmonella 
choleraesuis was not recovered from any tissues from group 3 
or group 4 pigs. 
Quantitative bacteriology was performed on the tonsil, 
ICJ, ICLN, and Cec Cont and is presented in Table 3. The 
level of infection in group 2 was not quantifiable at 6 weeks 
PI. At 6 weeks PI, group 1 tissues had a minimum of 2 logs of 
S. choleraesuis/g of tissue, the tonsil had the highest 
concentration of infection (4.78 logioCFU/g). At 15 weeks PI 
the tonsil was the only tissue from group 1 that had 
quantifiable numbers of S. choleraesuis (average 3.16 
log^oCFU/g). 
Serum antibody responses. The IgM response of group 1 to 
LPS antigen peaked 3 weeks PI at a (titer of 19) then 
decreased to undetectable numbers at 7 weeks PI (Fig 2). 
Groups 2 and 3 had low IgM titers to 3246 LPS (Fig 2). 
The IgM titer of group 1 to soluble antigen rose rapidly 
after inoculation to a peak of 563 at 3 weeks PI, then 
decreased to 115 at 5 weeks PI. A more gradual decrease in 
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titer was observed after 5 weeks PI (Fig 3a). The IgM titer 
of group 2 to soluble antigen was low throughout the 15 weeks 
(peak titer 20, 15 weeks PI; Fig. 3b). Group 3 IgM titers to 
soluble antigen increased to 19 at 1 week PI. The titers 
remained low (< 10) until 6 weeks PI when a marked rise in IgM 
response was observed for group 3 (peak 48). The titer then 
decreased until week 10 when the 2 remaining group 2 pigs were 
euthanized. 
Group 1 IgG titers to LPS antigen did not increase until 
weeks 6 and 7 PI. After week 7, the titer rose steadily to a 
peak titer of 1536 at week 12, which persisted until 15 weeks 
PI. The IgG titer of group 1 to soluble antigen increased 
steadily to 2112 (excluding week 6) until week 7 PI, then 
leveled off and remained at an approximate titer of 2100 until 
15 weeks PI (Fig 4a). 
Group 2 IgG titers to LPS were low (< 10) until 6 weeks 
PI when a peak titer of 116 was observed (Fig 4b). The IgG 
titer decreased to 10 at week 11 but then increased at weeks 
12 and 15 (peak titer 132 at 15 weeks). Group 2 IgG titers to 
soluble antigen were consistently low (less than 20) 
throughout the experiment (Fig 4b). The group 3 titers to LPS 
antigen also remained low until 6 weeks PI when a peak of 58 
was observed. Group 3 titers to soluble antigen were also low 
throughout the experiment (peak titer 20 7 weeks PI;Fig. 4b). 
Group 4 control pig titers, which were subtracted out of the 
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reported values, deviated from the day 0 bleed by a maximum 
titer of 8 (data not shown). 
Lymphocyte blastogenic responses. Groups 1 and 2 showed 
increased lymphocyte proliferation in response to 3246 
endotoxin as compared to the control group. Group 3 showed no 
increased sensitization of lymphocytes to 3246 endotoxin. 
Interestingly, the Si's of group 1 pigs remained below group 2 
Si's indicating some form of suppression of the proliferative 
response to 3246 endotoxin (Fig 5). 
The response of ConA stimulated peripheral blood 
lymphocytes was normal and not affected by INT exposure to 10® 
or 10^CFU of (groups 2 and 3) S. choleraesuis (data not 
shown). However, data indicate a suppression of the ConA 
stimulated lymphocyte mitogenic response following a 10' 
(group 1) INT dose of S. choleraesuis (data not shown). 
Discussion 
Although there is a considerable amount of information 
regarding acute S. choleraesuis infection in swine^'=^, there is 
little information regarding the carrier state and immune 
status of persistently infected swine. Reports suggest the 
main source of new S. choleraesuis infections is asymptomatic 
carrier swine^. Our study demonstrates an apparent dose 
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dependent correlation with the carrier state. 
Acute paratyphoid can be a difficult disease to reproduce 
in swine, requiring doses of 10" to 10" CFU of S. choleraesuis 
for production of acute disease^. Strain differences and 
differences in challenge protocols are likely responsible for 
some interstudy differences. One study reports moderate 
disease following a 10® CFU oral drench'. Gray et al."'" 
showed that intranasal inoculation of 10® CFU S. choleraesuis 
results in more severe clinical disease and greater magnitude 
of fecal shedding than gastric inoculation at the same dose. 
Therefore intranasal inoculation was chosen in this study in 
order to maximize response to the pathogen. 
It is not surprising that group 1 pigs exhibited marked 
clinical signs indicative of acute S. choleraesuis infection. 
In comparison, group 2 pigs exhibited only mild clinical 
disease which, in a large production setting, would likely not 
have been noticed. Interestingly, group 3 pigs exhibited no 
clinical signs of disease. Gray et al.^°'" also demonstrated 
that a 10® intranasal challenge using strain 3246 results in 
severe clinical disease. Together these results demonstrate 
that experimental infection of swine with a dose of 10' CFU or 
higher will result in severe clinical disease and a long term 
carrier state. At moderate doses, less than 10' but above 10^, 
inoculation will likely result in mild clinical disease and a 
short term carrier state of at least 9 weeks. A dose of less 
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than 10^ will be cleared with no apparent shedding of the 
organism. 
The magnitude of fecal shedding for groups 1 and 2 
indicate a direct relationship between dose and shedding 
magnitude. Interestingly, regardless of dose, the pattern of 
shedding was similar between groups. Peak shedding was 
observed on day 5 for both groups and declined by 1 week PI. 
Groups 1 and 2 demonstrated an increase in shedding at 5 weeks 
and 7 weeks, respectively. S. choleraesuis was only 
sporadically recovered from fecal pools after 7 weeks for 
group 1 and 5 weeks for group 2. These data indicate that 
regardless of dose, an intermittent paradigm of shedding 
occurs in carrier animals. These data also indicate that 
carrier swine may shed S. choleraesuis for at least 15 weeks 
PI as observed in group 1. Furthermore, the results also show 
that negative fecal cultures are not a reliable measure of 
herd or individual animal status. This underscores the need 
for a reliable test or multiple testing under current 
methodologies to identify infected animals. Similar results 
have been shown with naturally occurring S, typhimarium 
infections, where shedding was observed after prolonged 
periods of negative fecal cultures*'"'^*. 
The acute phase response induced by exposure to S. 
choleraesuis has been described by Kramer et al". The ESR 
assay was used in this study as a non-specific measurement of 
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acute phase response. We observed that increased 
sedimentation rates of groups 1 and 2 correlated with the 
febrile response and clinical signs caused by acute S, 
choleraesuis infection. The ESR values returned to normal as 
pigs recovered from acute infection. However, no correlation 
with clearance of the bacteria could be made. 
The post mortem bacteriologic data did not indicate that 
a persistent infection occurred after challenge with a 10^ 
dose of S. choleraesuis. However, IgM and IgG antibody titers 
observed for group 3 indicate that bacteria were present for a 
sufficient period of time to induce at least a weak immune 
response. Interestingly, a blastogenic response to S. 
choleraesuis antigens was not observed for group 3. This may 
be attributed to assay sensitivity and thus mild responses may 
have been missed. In addition, a blastogenic response may 
have been observed with more frequent sampling and/or 
continued sampling beyond 6 weeks PI. 
A 10® dose resulted in infection for at least 6 weeks PI 
and fecal shedding was detected until 9 weeks PI. However, S. 
choleraesuis could not be recovered from tissue or feces from 
group 2 pigs after 9 weeks PI. A measurable antibody response 
was also observed in this group, as well as an antigen 
specific blastogenic response. These results indicate that 
experimental infection with 10' CFU of S. choleraesuis results 
in a carrier state with detectable shedding for at least 9 
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weeks PI. The cellular and humoral immune response observed 
appear to correlate with clearance of the organism. 
A dose of 10® resulted in a long term carrier state. At 
15 weeks PI the pigs in group 1 continued to shed S. 
choleraesuis and had multiple tissues positive for S. 
choleraesuis. In addition, we observed an average of 3 logs 
of S. choleraesuis/g of tonsil at 15 weeks PI. Gray et al.^^ 
has shown that high tonsil populations of S. choleraesuis is 
indicative of the carrier state. The carrier state observed 
in this group of pigs was present despite antibody titers and 
a measurable cellular response to S. choleraesuis antigens. 
This suggests that the immune system may be overwhelmed by 
such a large dose. 
At low doses (10^), S. choleraesuis is unable to 
stimulate a measurable antigen-specific lymphocyte response; 
however, normal mitogenic responses were observed. At 
moderate doses, between 10® and 10' optimal antigen stimulation 
of lymphocytes occurs as well as normal mitogenic responses. 
At these moderate doses the immune response observed here and 
in other studies^^ is apparently successful at greatly reducing 
the pathogen load in the host. 
In contrast, at higher doses (10®), S. choleraesuis 
causes some degree of antigen-specific and non-specific 
suppression of lymphocyte activation. One reason for the 
increased shedding and level of infection observed in group 1 
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may be the observed lymphocyte suppression. A long term 
carrier state occurred in group 1 despite a measurable humoral 
response and a suppressed cellular response. The observed 
immunosuppression is likely an important factor in the 
pathogenesis of S. choleraesuis in swine and our observations 
suggest that it may play an important role in development of a 
carrier state. Immune suppression by S. typhimurium infection 
in chickens and its effect on the carrier state has been 
described by Hassan and Curtiss^®. 
In conclusion, these data indicate that the magnitude of 
shedding and persistence of infection after S. choleraesuis 
infection is dose dependent. Low doses of S. choleraesuis can 
be easily cleared, moderate doses can persist for at least 2 
months, and high doses result in a long term carrier state. 
Regardless of dose, cellular and humoral immune activation 
occur after inoculation. However, at high doses, S. 
choleraesuis causes signs of lymphocyte suppression, which may 
affect the ability of the immune system to eliminate the 
bacteria. These data provide an important model for future 
investigation of S. choleraesuis infection in swine. 
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Figure Legends 
Fig 1. Quantitative recovery of S. choleraesuis from fecal 
pools (a) group 1 (10® CFU) or (b) group 2 (10® CFU). Reported 
values are the MPN/g of feces for each group. 
Fig 2. Serum IgM response of swine to S. choleraesuis LPS 
antigen following challenge with S. choleraesuis at a 10' 
(group 1), 10® (group 2) or 10^ (group 3) CFU dose. Reported 
values are the mean ELISA titer minus the mean uninoculated 
control value. Vertical bars represent the standard error of 
the mean. 
Fig 3. Serum IgM response of swine to S. choleraesuis soluble 
antigen following challenge with S. choleraesuis (a) 10' 
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(group 1), (b) 10® (group 2) or 10® (group 3) CFU dose. 
Reported values are the mean ELISA titer minus the mean 
uninoculated control value. Vertical bars represent the 
standard error of the mean. 
Fig 4. Serum IgG response of swine to S. choleraesuis LPS or 
soluble antigen following challenge with S. choleraesuis (a) 
10' (group 1), (b) 10® (group 2) or 10® (group 3) CFU dose. 
Reported values are the mean ELISA titer minus the mean 
uninoculated control value. Vertical bars represent the 
standard error of the mean. 
Fig 5. Lymphocyte blastogenic response of swine to S. 
choleraesuis endotoxin following challenge with 10' (group 1), 
10® (group 2)or 10® (group 3) CFU dose or uninoculated control 
(group 4). Assays were performed at days 7,14,28 and 42 post 
inoculation. Error bars represent the standard error of the 
mean. 
Table 1 - Number of samples positive for S. choleraesuis from 
tonsil, nasal, rectal swabs and fecal pools 
Day Week 
Sample DO O
 
i 1 
D2 D3 D5 D8 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Tonsil 0" 5 3 4 4 4 3 2 3 4 4 2 2 0 2 11 0 1 1 
Nasal 0 4 2 4 5 4 1 0 0 2 0 1 0 0 0 0 0 0 0 0 
Rectal 0 4 2 0 4 4 4 1 2 2 1 0 0 0 0 10 0 1 0 
n= 5" 5 5 5 5 5 5 5 5 5 5 2 2 2 2 2 2 2 2 2 
F e c a l "  - " +  +  - +  +  + +  +  +  + +  +  -  +  +  - -  -  +  
Tonsil 0 2 420 1 00000000000 0 0 0 
2 Nasal 0 1 120 1 00000000000 0 0 0 
Rectal 0 0 123 1 00000001000 0 0 0 
n =  5  5  5 5 5  5 5 5 5 5 5 2 2 2 2 2 2  2  2  2  
F e c a l  -  -  +  +  +  +  + +  +  - - < - +  +  +  - -  - -  -  -
a- Number of swabs positive for S. choleraesuis 
b- Number of pigs sampled 
c- Ten sample fecal pool; qualitative results only 
d- Results reported as S. choleraesuis present(+) or absent( 
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Table 2 - Qualitative recovery of S. choleraesuis from the 
tissue of experimentally infected swine. 
Number of positive samples/Number of pigs necropsied 
Group 1 2 3 
Tissue 6" 15" 6" 15" 6" 10° 
Tonsil 2V3 2/2 0/3 0/2 0/3 0/2 
Lung 1/3 0/2 0/3 0/2 0/3 0/2 
Spleen 0/3 0/2 0/3 0/2 0/3 0/2 
Liver 1/3 0/2 0/3 0/2 0/3 0/2 
ICJ 2/3 1/2 0/3 0/2 0/3 0/2 
ICLN 2/3 1/2 1/3 0/2 0/3 0/2 
Cecum 2/3 2/2 0/3 0/2 0/3 0/2 
Cec Cont 2/3 2/2 0/3 0/2 0/3 0/2 
Colon 2/3 2/2 0/3 0/2 0/3 0/2 
a -
b -
c -
6 week necropsy 
15 week necropsy 
10 week necropsy 
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Table 3 - Mean populations of S. choleraesuis recovered from 
tissues of pigs challenged with 10® CFU (group 1). 
S, choleraesuis logiog/tissue 
Week Tonsil ICJ ICLN Cec Cont 
6" 4.77 2.24 2.10 2.51 
15" 3.16 NQ-P° NQ-P NQ-P 
a. n=3 
b. n=2 
c. NQ-P - not quantifiable but positive by 
qualitative bacteriology 
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Summary 
The purpose of this experiment was to study the natural 
transmission of S. choleraesuis in swine. Group 1 (n=12) was 
challenged with 10® S. choleraesuis by intranasal inoculation. 
One day post inoculation (PI) group 2 (n=24) was commingled 
with group 1. Pigs were necropsied at 1,2,4,6,9 and 12 weeks 
PI. Pigs in group 1 were shedding 2.61 log^o CFU/g feces prior 
to commingling. Swabs and group fecal pools indicated that 
group 2 pigs were shedding S. choleraesuis 1 day after 
commingling. At 1 week PI 32/32 group 1 tissues were positive 
for S. choleraesuis while 39/62 tissues were positive for 
group 2. At 12 weeks PI only group 2 had positive tissues. 
These data indicate that naive swine exposed to swine shedding 
a relatively low amount of S. choleraesuis can be infected and 
shed S. choleraesuis within 24 hours of exposure. However, 
under well managed conditions, the level of S. choleraesuis 
can be significantly reduced in naturally exposed swine. 
Intxoduction 
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Salmonella choleraesuis is a host adapted, facultative 
intracellular pathogen that causes swine paratyphoid (26). It 
is the most frequent Salmonella serotype recovered, from swine 
(10) and was isolated from >95% of swine salmonellosis 
outbreaks in Iowa in 1989 (20). The National Animal Health 
Monitoring Survey estimated that swine salmonellosis is 
responsible for 28 million dollars in annual production losses 
in Iowa and 100 million in losses nationwide (20). 
Although S. choleraesuis is the most frequent porcine 
isolate, it is rarely isolated from swine feed or non-porcine 
Salmonella reservoirs. The source of S. choleraesuis seems to 
be limited to carrier pigs and facilities previously 
contaminated with this serotype (26). The carrier state of S. 
typhimurium (27, 31), as well as S. choleraesuis (12), in 
swine have been described after experimental infection. 
Epidemiological studies have indicated crowding and contact 
with infected feces increased infection rates (14, 17). 
However, these studies did not provide specific data involving 
infection levels of individual animals. Fedorka-Cray et al. 
(7) studied the natural transmission of S. typhimurium to 
swine and observed a short term carrier state after exposure 
to low concentrations of S. typhimurium in the environment. 
Similar information involving S. choleraesuis infection is not 
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available. While there are no data available describing the 
carrier state after natural transmission of S. choleraesuis in 
swine, Hinton (15) studied naturally occurring Salmonella 
infections in cattle and chickens. He concluded that 
naturally occurring infection patterns were different from 
those observed for experimentally infected animals and 
suggested that natural infection models are important for 
understanding salmonellosis. 
The purpose of this experiment was to study shedding 
patterns, tissue colonization and the immune response after 
natural transmission of S. choleraesuis in swine and determine 
if a carrier state can develop following contact with 
experimentally infected pigs. 
Materials and Methods 
Bacterial strains and challenge cultures. Wild type S. 
choleraesuis var. kunzendorf jj;3246 (16), kindly provided by 
the laboratory of Roy Curtiss III, Washington University, St 
Louis, MO, was used to challenge a 12 week old pig by 
intranasal inoculation and redesignated 3246pp as previously 
described (12). The strain has a naturally acquired 
resistance to streptomycin. Challenge cultures were prepared 
by inoculating 10 ml of LB broth with 100 /iL of a -70 frozen 
stock culture of 3246pp. The culture was grown overnight at 
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37°C on an orbital shaker at 150 rpm. A 1% inoculum was 
transferred into fresh LB broth and grown for 3.5 hours at 
37°C and 220 rpm. The culture was centrifuged, the pellet was 
resuspended in 1/2 volume of phosphate buffered saline (PBS) 
and adjusted to a final concentration of 1x10® CFU/ml (0D6oo= 
0.123) in PBS. 
Experimental design. After farrowing, source sows were 
tested and confirmed to be negative for Salmonella spp. by 
bacteriologic culture as described below. At two weeks of 
age, 40 pigs were weaned and transported to isolation 
facilities as previously described (8). Tonsil (T), nasal (N) 
and rectal (R) swabs were taken from pigs at 2, 3, 4 and 6 
weeks and cultured for Salmonella spp. At 6 weeks of age the 
pigs were randomly divided into three groups. Pigs were 
housed in a climate controlled, fully enclosed environment on 
concrete floors. Each group was housed in separate isolation 
facilities and allowed to acclimate to the new environment for 
1 week. Feces was physically removed and the pen was washed 
with water once daily throughout the experiment. At 7 weeks 
of age (day 0) the group 1 pigs (n=12) were inoculated 
intranasally (INT) with 1 ml (0.5 ml in each nostril dropwise 
on inspiration, alternating nostrils) of 3246pp at 1x10® 
CFU/ml. One day post inoculation (PI) group 2 naive pigs 
(n=24) were commingled with the group 1 pigs. Group 3 (n=4) 
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seirved as uninoculated controls. 
Feces was collected (10-20 g samples) from individual 
pigs (>60% of the pigs per group) in group 1 and 2 and swabs 
(T, N, R) on all pigs were obtained on days 1 through 6, 8, 9, 
11, 13, 16, 19, 23, 26, 30 then weekly. Fecal pools for each 
group were obtained by combining approximately 2 grams of 
feces from each pig per group. The S, choleraesuis 
environmental load was measured by scraping all available 
feces into a pile, mixing well and taking a 20-30 g sample. 
Two pigs from group l and 4 pigs from group 2 were 
euthanized and necropsied at 1, 2, 4, 6, 9 and 12 weeks PI. 
One pig from group 3 was necropsied at 1, 4, 9 and 12 weeks 
PI. Tissues were collected aseptically for bacteriologic 
examination (sterile gloves and instruments were used for each 
tissue). Tissues included the turbinate (1 g; approximate 
weight), tonsils (4 g), thymus (3 g), mandibular lymph nodes 
(mandib-LN; 3 g), trachea (1 g), esophagus (1 g), lungs (8 g), 
bronchial lymph nodes (bronch-LN; 2 g), stomach wall (stom 
wall; 2 g), spleen (5 g), liver (5 g), middle ileum (ileum-
mid; 4 g), ileocolic junction (ICJ; 6 g), ICLN (3 g), cecum (4 
g), and colon (4 g); stomach contents (stom cont; 20 g) and 
cecal contents (cec cont 25 g). 
Clinical signs. Rectal temperatures and clinical signs 
were monitored 2 times daily until day 3 PI for pigs in all 
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groups. Between days 4 and 14 PI, pigs were monitored once 
daily then once weekly after day 14 PI. 
Bacteriologic examinations. Tissue samples and fecal 
pools were processed as previously described (12). All T, N, 
R swabs, fecal pools and tissues (collected at necropsy) were 
incubated at 37°C in GN-Hajna (GN; Difco, Detroit, MI ) broth 
for 18 to 24 hours then streaked on brilliant green agar with 
sulfadiazine (BGS; Microdiagnostics, Lombard, IL). 
Additionally, at 18 to 24 hours 100 /il of the GN broth was 
transferred to Rappaport-Vassiliadis (RV) medium (24), 
incubated at 37°C for 18 hours, then streaked to BGS. All BGS 
plates were incubated 24 hours at 37°C. In order to 
facilitate recovery and identification of the challenge 
strain, streptomycin sulfate (200 /xg/ml; Sigma, St. Louis, Mo) 
was added to media used for group 1 and 2 pigs. 
Colonies having the typical appearance of Salmonella were 
picked and inoculated into triple sugar iron and lysine iron 
agar slants. Positive isolates were confirmed as serogroup C 
by agglutination with Salmonella antiserum group CjO (Difco, 
Detroit, MI). Representative isolates were serotyped at the 
National Veterinary Services Laboratory. Quantitative 
bacteriology was conducted using the 5 tube most probable 
number (MPN) method (30) with GN, BGS-S and RV media as 
described above and are reported as the mean of the respective 
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group for each necropsy day. Differences between groups were 
evaluated by the test. 
Antigen preparation. Salmonella choleraesuis 3246 LPS 
antigen was prepared by the method of Westphal(25) and 
lyophilized for use in ELISA assays. 
Endotoxin from S. choleraesuis 3246pp was prepared by the 
method of Morrison (18) and lyophilized for use in the 
lymphocyte blastogenesis assays. Heat extract antigen (HE) 
from S. choleraesuis 3246pp was prepared as previously 
described (12). 
Protein determination. Total protein was determined by 
the method of Bradford (2) using bovine serum albumin as the 
standard. 
Intestinal antibody. Local intestinal antibody secretion 
was measured in intestinal wash collected as previously 
described (6). 
Antibody responses. Antibody responses in serum and 
intestinal washes were determined by ELISA assay as previously 
described (12) except that serum samples were diluted 1/10 in 
diluent buffer. Values are reported as optical densities plus 
or minus the standard error of the mean for the pigs in each 
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group and not as titers. 
Lymphocyte Blastogenesis Assays. Blastogenesis assays 
were perfoirmed at weeks 1, 2, 4, 6, 9 and 12 weeks PI on 4 
pigs from group 1 (2 pigs selected for necropsy plus 2 others; 
except at 12 weeks when only 2 pigs were available), 4 pigs 
from group 2 (pigs selected for necropsy) and all available 
group 3 pigs. Assays were performed as described previously 
(12) except that lymphocytes were incubated with the 
respective antigen for 48 hours and 5 day incubations were not 
performed. Lymphocytes were incubated with either S. 
choleraesuis endotoxin (18) at 50.0 ng/ml or HE antigen (12) 
at 10.0 /ng/ml. Positive control wells contained concanavalin 
A (ConA; Sigma) at 5.0 Negative control wells 
contained cells and media only. Values are reported as the 
mean stimulation index (SI; defined as experimental values 
divided by negative control values) plus or minus the standard 
error of the mean for the pigs in each group. 
Results 
Clinical signs. No clinical signs were observed on day 1 
PI (day of commingling). Pigs in group 1 first elicited a 
febrile response on day 2 which peaked at 41.2"c 4 days PI and 
persisted until day 11 PI. Group 2 pigs also developed a 
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febrile response on day 3 PI (day 2 post-commingling, PC) 
which peaked at 41.4°C on day 5 PI and persisted until day 8 
PI. Severe clinical signs including diarrhea, chills, 
respiratory distress and severe depression were observed in 
both groups between days 2 and 10 PI. Clinical signs in both 
groups were resolved by day 14 PI. 
Antemortem bacteriologic results. All source sows were 
culture negative for Salmonella spp. All pigs were also 
culture negative for Salmonella spp. prior to challenge. 
Following challenge, T, N, R swabs indicated that all of the 
group 1 pigs were shedding S. choleraesuis on day 1 PI. A 
combination of R swabs and fecal cultures indicated at least 
16% (4/24) of the pigs in group 2 were shedding S. 
choleraesuis by day 2 PI or 24 hours PC. By day 4 PI at least 
50% (12/24) of group 2 pigs were shedding S. choleraesuis and 
88% (21/24) of the group 2 pigs were confirmed to be shedding 
S. choleraesuis (antemortem culture) by day 11 PI. 
The magnitude of fecal shedding for groups 1 and 2 and 
the environmental load of S. choleraesuis is presented in 
Table 1. At the time of commingling the environmental load 
was 2.61 log^o CFU S. choleraesuis/g feces. Fecal shedding in 
group 1 peaked on day 8 PI (3.65 log^o CFU/g), while group 2 
peaked on day 9 PI (1.51 log^o CFU/g; day 8 PC). With the 
exception of days 6, 8, and 9 PI, the environmental fecal 
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levels followed the group 1 fecal levels closely. The last 
positive fecal culture was observed at 8 weeks PI for group 2. 
Postmortem bacterxologic examination. The frequency of 
recovery of S. choleraesuis from individual tissues is 
presented in Tables 2 and 3 for groups 1 and 2, respectively. 
Salmonella choleraesuis was recovered from nearly all of the 
tissues cultured from group 1 at the 1 (100%) and 2 (81%) week 
PI necropsies. At the 4, 6 and 9 week necropsies the numbers 
of tissues found to be infected declined to numbers observed 
previously (31%,47%,19%, respectively)(12). Similarly, at 
weeks 1 and 2 (when clinical disease was observed) S. 
choleraesuis could be found at high frequency in many tissues 
for group 2 pigs and 4/4 pigs were positive for both the 1 and 
2 week necropsy . The tissues in which S. choleraesuis was 
most frequently recovered in group 2 were the ICJ (50%), ICLN 
(42%), cec cont (42%) and cecum (33%). During the subclinical 
carrier state (4-12 weeks) the tissues most frequently 
positive for S. choleraesuis in group 2 were the ICJ (25%), 
ICLN (19%), cec cont, colon and CLN (13%). 
Nearly all of the group 1 pigs were tissue positive for 
S. choleraesuis (10/12). However, the 2 pigs necropsied at 12 
weeks were negative. All of the group 2 pigs (8/8) were 
tissue positive at the 1 and 2 week necropsies and 3/4 were 
positive at the 4 week necropsy. One group 2 pig was tissue 
155 
positive at each of the 6, 9 and 12 week necropsies. 
Quantitative bacteriology for groups 1 and 2 is presented 
in Table 4. Relatively high populations of S. choleraesuis 
were found in the tonsils, lung, ICLN, ICJ and cec cont at 1 
week for both group 1 and 2. The lung of group 2 was the 
lowest (1.49 logio CFU/g) and, except for the lung, the 
populations were similar between groups. High populations (> 
3.96 logj.0 CFU/g) were observed for group 1 in the tonsils 
through 9 weeks PI (excluding week 2). The ICLN, ICJ and cec 
cont were also highly populated through 6 weeks PI. For group 
2 populations >1.47 logio CFU/g were observed in the lung 
through 2 weeks PI. Quantifiable amounts of S. choleraesuis 
were observed in group 2 in the cec cont through 4 weeks PI, 
the ICJ through 9 weeks PI (excluding 6 weeks PI) and the ICLN 
through 6 weeks PI. 
Serum and intestinal antibody responses. Serum antibody 
responses to S. choleraesuis LPS for groups 1 and 2 are 
presented in figure la and lb for IgG and IgM, respectively. 
High serum IgG responses to S. choleraesuis LPS were observed 
beginning 2 weeks PI for both groups which continued to rise 
until 5 and 6 weeks for groups 2 and 1, respectively. The 
group 2 response, although slightly lower, paralleled the 
group 1 response closely. The serum IgM response for group 1 
was observed within 1 week PI while the group 2 IgM response 
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was observed within 2 weeks PI. The IgM response peaked for 
both groups at 2 weeks PI. As observed for the IgG response, 
the group 2 response paralleled the group 1 response closely. 
Serum IgA responses were not observed for either group. 
Intestinal IgG, IgM, and IgA responses to 3246pp LPS are 
presented in figures 2a, 2b and 2c, respectively. A low 
mucosal IgG response was observed for group 1, 1 week PI 
which increased markedly, peaked at 6 weeks PI, and declined 
steadily until 12 weeks PI. The intestinal IgG response for 
group 2 was not observed until 2 weeks PI and then remained 
constant from 4 to 12 weeks PI. An IgM response was observed 
for both groups 1 and 2 beginning at 1 week PI and continuing 
throughout the experiment. The highest response was observed 6 
weeks PI for group 1 and at 12 weeks PI for group 2. 
Figure 2c indicates a low intestinal IgA response to S. 
choleraesuis LPS antigen for both groups beginning at 1 week 
PI which declined and continued until 12 weeks PI. Although 
higher responses may have occurred at weeks 1 and 12 PI the 
large error bars make this result unclear. 
Blastogenic responses. Lymphocytes from group 1 and 
group 2 pigs showed similar increased proliferation to S. 
choleraesuis HE antigen beginning at 4 weeks PI as compared to 
controls. Increased sensitivity to HE antigen persisted 
through 9 weeks PI before returning to normal levels at 12 
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weeks PI (figure 3). Similar trends were observed with S. 
choleraesuis endotoxin. 
Discussion 
This experiment was conducted to study the natural 
transmission of S. choleraesuis within swine herds, determine 
the effect of natural transmission on the carrier state and 
compare the natural disease syndrome to experimentally 
infected pigs. 
Pigs infected with S. choleraesuis usually begin to show 
clinical signs between 36 and 48 hours after infection 
(12,19). We designed this study so that pigs were commingled 
before clinical disease was evident. This represented a real 
world scenario mimicking field conditions such as when new 
stock is purchased or when swine are moved and regrouped into 
new pens and exposed to infected swine which are not 
manifesting clinical signs. 
It has been shown that experimentally infected swine shed 
between 10^ and 10® CFU/g of feces during peak clinical disease 
(12,21). It is unclear however, how this magnitude of 
shedding relates to that of natural infections and 
subsequently to the transmission of S. choleraesuis to naive 
swine. We have demonstrated that naive swine exposed to a 
population shedding as little as 2.61 log^o CFU/g of feces will 
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begin shedding S. choleraesuis within 24 hours of exposure. 
In addition, severe clinical signs were observed in group 2 
within 3 days of exposure to the experimentally infected 
population. This indicates that exposure to relatively low 
concentrations of S. choleraesuis may result in high morbidity 
and initiate a severe outbreak of swine paratyphoid within a 
relatively short period of time. This not only indicates the 
rapidity of S. choleraesuis transmission on the farm but may 
also translate to transmission and spread of Salmonella spp. 
during transport and time in lairage before slaughter. 
Nearly all (88%) of the naive pigs were confirmed by 
swabs or fecal cultures to be positive for S. choleraesuis by 
11 days PI indicating that the majority of swine exposed to a 
population shedding between 2 and 3 logs of S. choleraesuis 
per g of feces will become short term S. choleraesuis 
shedders. 
Interestingly, although the clinical signs of group 2 
were similar to group 1 in severity and duration, peak 
shedding was at least 2 logs lower (1.5 log^o CFU/g of feces 
for group 2 vs. 3.6 log^o CFU/g for group 1). This indicates 
that the high levels of shedding observed after experimental 
infection may not be indicative of shedding magnitude after 
natural infection. 
The tissue distribution of S. choleraesuis in swine after 
experimental infection has been described for clinical 
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infection (4, 19, 21, 28) and the carrier state (12). The 
tissue distribution observed for group 1 was similar to other 
studies for both clinical and subclinical infection periods. 
However, in comparison to experimental infection some 
differences were observed for the naturally infected group 2 
pigs. High concentrations of S- choleraesuis were observed in 
the tonsils for both groups at 1 week PI. This suggests that 
either the tonsils became colonized due to a septicemia or 
that it is a primary site of invasion for S. choleraesuis. 
Gray et al. demonstrated that tonsil populations declined to 
zero by 2 weeks PI then increased during the later time points 
of the experiments following experimental S. choleraesuis 
challenge (12). This result was also observed at weeks 2, 4, 
6 and 9 PI for group 1 in this experiment (Table 4). The 
tonsils have been described as an important subclinical 
carrier state tissue for S. choleraesuis (12,13) and S. 
typhimurium (31) after experimental infection- Interestingly, 
in this study after the 1 week necropsy, tonsil populations 
were not observed in the group 2 pigs. It is unclear whether 
tonsil populations during subclinical disease (>2 weeks PI) is 
reserved as an artifact of high dose experimental infection or 
is triggered by an unknown factor not present in the group 2 
model. The results presented here suggest that positive 
tonsil cultures may also indicate a very recent exposure to 
Salmonella spp. 
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Pneiamonia associated with S. choleraesuis infection has 
been previously described (1) and a recent increase in S. 
choleraesuis associated pneumonia has been reported (23). It 
is unclear whether this predilection for the lung is due 
solely to the pathogen, poor ventilation in large confinement 
buildings or some combination of these and other factors. 
Experimental infection models have not provided good answers 
because positive lung samples have been regarded as an 
artifact of intranasal or per os inoculation. The data 
presented here indicates that the lung is a site of initial 
infection of S. choleraesuis in naturally exposed pigs. We 
recovered S, choleraesuis from 6/8 lungs of the naturally 
infected, group 2 pigs during the first two weeks of 
infection. The concentrations of S. choleraesuis in the lung 
remained at 1.5 log^o CFU/g through 2 weeks PI in the naturally 
exposed group. 
Swine have a large number of alveolar macrophages in the 
lung (29). Fedorka-Cray et al. (9) hypothesized that swine 
alveolar macrophages may have an impaired ability to contain 
Salmonella within the early hours after infection. In 
addition, the alveolar macrophages may act as a vehicle for 
dissemination of Salmonella. Our data demonstrates that after 
natural infection there is a population of Salmonella which 
resides in the lung for at least 2 weeks after exposure 
possibly residing in alveolar macrophages and acting as a 
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- continual source of infection. 
Overall the tissues in which S, choleraesuis can most 
frequently be found in naturally infected pigs are the ICJ, 
ICLN, cec cont and cecum. During clinical disease (< 2 weeks 
PI) S. choleraesuis was isolated from many of the same tissues 
in group 2 as is observed with field outbreaks and 
experimental infections (26). During the subclinical carrier 
state the tissues of predilection are the ICJ, ICLN, cec cont, 
colon, CLN and cecum in the naturally infected, group 2 swine. 
This is similar to the tissue distribution which has been 
described after experimental infection of swine with either S. 
typhinurium (27, 31) or S. choleraesuis (12). The sole 
exception is that the tonsils were not positive in the 
subclinical group 2 pigs. 
The data presented here indicates that only 1 of 4 group 
2 pigs was positive at each of the 6, 9, and 12 week 
necropsies suggesting two things. First, even after a severe 
clinical outbreak of swine paratyphoid the numbers of S. 
choleraesuis carried in deep tissue and present in the 
environment was markedly reduced in the group 2 pigs. A 
significant (P < 0.01) number of naive pigs were able to clear 
S. choleraesuis between 9 and 12 weeks PI, indicating that not 
all pigs will become long term carrier animals. Although no 
management protocols were tested here, tliis data suggests that 
good management practices can control and significantly reduce 
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S. choleraesuis in swine herds. 
Secondly, these data suggests that a small fraction of 
carrier pigs is responsible for maintenance of this pathogen 
in the swine population. It has been shown that S. 
choleraesuis is a serotype that is rarely isolated in feeds or 
the environment (26) implicating subclinical carrier swine in 
new outbreaks. It remains a mystery, however, as to the 
factors which induce carrier swine to shed levels necessary to 
initiate a new outbreak. 
Experimental infection models have used doses ranging 
from 10® to 10" CFU of S. choleraesuis (26). Gray et al. (13) 
and others (5) have shown that experimental infection with a 
dose of 10® CFU causes moderate disease. In contrast, a dose 
of 10^ CFU of S. choleraesuis is cleared with no clinical 
signs and no apparent shedding (13). In this study, group 2 
swine were exposed to a population shedding a maximum of 3.6 
logio CFU/g of feces with a maximum environmental load egual to 
3.0 log^o CFU/g of feces. In comparison to experimental 
models, the group 2 swine would have needed to ingest between 
250 g (10® CFU dose) and 25000 g (10® CFU dose) of feces each 
to manifest the severe clinical signs observed in group 2. 
This amount of coprophagia is unlikely. 
Previous studies have shown swine have a dose dependant 
immune response to S. choleraesuis (13). In the present study 
the humoral and cellular immune responses were similar between 
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the group 1 and group 2 pigs suggesting they received nearly 
the same dose or the organism was able to replicate to nearly 
the same concentrations in the host. Taken as a whole, these 
data indicate that during natural transmission the infectious 
dose of S. choleraesuis is much lower than experimental models 
have previously described. It may also be that pigs are 
exposed to a large dose of S. choleraesuis by a mechanism 
other than fecal oral transmission. The latter possibility 
would necessitate large populations of S. choleraesuis are 
excreted by infected swine by a route other than feces such as 
mucous or urine. However these high concentrations cannot be 
confirmed in the environmental samples. Fedorka-Cray et al. 
(9) has hypothesized that routes other than fecal/oral are 
important in the pathogenesis of swine salmonellosis. 
A more likely hypothesis is that there are factors 
involved in the natural transmission of S. choleraesuis which 
are not reproduced in experimental infection. Some of these 
factors may include the virulence of the S. choleraesuis 
following passage through the host which may allow lower 
infectious doses and may allow the organism to replicate to 
high concentrations in the host. In vitro studies have shown 
the importance of the expression of induced antigens for 
intracellular survival (3,11,22). Other factors involved in 
the transmission of S. choleraesuis may include the unknown 
affect of multiple inoculations with smaller doses and 
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inoculation mechanisms not reproduced during experimental 
infections. Some combination of these and other factors is 
likely. 
As discussed previously the humoral, mucosal and cellular 
immune response observed for the group 2 swine closely 
paralleled that of group 1. This indicates that in terms of 
immune parameters, the experimental infection may be an 
appropriate model for study of this response. In addition, 
this indicates that serum collected from experimentally 
infected swine provide a useful tool for the development of 
serologically based Salmonella detection tests. 
In conclusion, this model for S. choleraesuis 
transmission provides a dramatic example of the difference 
between infection with Salmonella grown the laboratory versus 
the natural host and should be seen as a basis for design of 
future animal studies. 
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Table 1 - Magnitude of fecal shedding for Group 1 
(intranasally challenged), Group 2 (naturally exposed) and 
environmental (envir) load of S. choleraesuis. 
Feces (logio CFU/g) 
Day Group 1 Group 2 Envir 
D1 2.61 NA" 2.61 
D2 1.55 +" 2.55 
D3 2.55 + 1.86 
D4 ND® 0.64 2.29 
D5 3.26 + 2.98 
D6 3.35 0.46 1.6 
D8 3.65 0.83 2.03 
D9 2.97 1.51 2.25 
Dll 2.7 0.31 1.62 
D13 1.73 0.43 1.0 
D16 2.08 1.11 1.81 
D19 1.72 0.49 1.35 
D23 2.45 _<i 1.08 
D26 1.11 0.59 1.11 
D30 2.25 - 2.1 
D34 1.77 - 0.55 
6 week - - -
7 week 0.75 - 1.11 
8 week - 0.63 -
9 week — — — 
a- not applicable 
b- positive by enrichment only 
c- not done 
d- negative 
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Table 2 - Number of S. choleraesuis positive tissues from 12 
Group 1 intranasally challenged pigs. 
Necropsy week fn=2'> 
Tissue 1 2 4 6 9 12 % Pos. 
Turbinate 2 2 0 0 0 0 33% 
Tonsils 2 0 1 1 1 0 42% 
Thymus 2 0 0 0 0 0 17% 
Mandib-LN 2 2 1 1 0 0 50% 
Lung 2 2 0 0 0 0 33% 
Bronch-LN 2 2 0 0 0 0 33% 
Stom wall 2 0 0 0 0 0 17% 
Spleen 2 2 0 0 0 0 33% 
Liver 2 2 1 1 0 0 50% 
Ileum-mid 2 2 0 1 0 0 42% 
ICJ 2 2 2 2 1 0 75% 
ICLN 2 2 2 2 0 0 67% 
Cecum 2 2 0 1 1 0 50% 
Cec Cont 2 2 2 2 1 0 75% 
Colon 2 2 1 2 1 0 67% 
CLN 2 2 0 2 1 0 58% 
% Pos. 100% 81% 31% 47% 19% 0 
Pigs Pos. 2 2 2 2 2 0 
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Table 3 - Number of S. choleraesuis positive tissues from 24 
Group 2 naturally exposed pigs. 
Necropsy week (n=4) 
Tissue 1 2 4 6 9 12 % Pos 
Turbinate 0 0 0 0 0 0 0 
Tonsils 3 1 0 0 0 0 17% 
Thymus 0 0 0 0 0 0 0 
Mandib-LN 0 0 0 0 0 0 0 
Lung 4 2 0 0 0 0 25% 
Bronch-LN 3 3 0 0 0 0 25% 
Stom wall 0 1 0 0 0 0 4% 
Spleen 4 1 0 0 0 0 21% 
Liver 4 3 0 0 0 0 29% 
Ileum-mid 0 2 0 0 0 0 8% 
ICJ 4 4 3 0 1 0 50% 
ICLN 3 4 2 1 0 0 42% 
Cecum 4 3 1 0 0 0 33% 
Cec Cont 4 . 4 2 0 0 0 42% 
Colon 3 0 0 1 0 1 21% 
CLN 3 1 0 1 0 1 25% 
Percent Pos 61% 44% 13% 5% 2% 3% 
Pigs Pos 4 4 3 1 1 1 
174 
Table 4 - Mean populations of S. choleraesuis recovered from 
tissues of pigs challenged by intranasal (group 1) or by 
natural exposure (group 2). 
Log^o CFU/g tissue S. choleraesuis 
Group 1; n=2 
Week Tonsils Lung ICLN ICJ Cec Cont 
1 4.05 4.69 6.73 5.56 4.35 
2 1.20 4.70 5.43 3.67 
4 4.47 - 1.32 3.79 2.17 
6 3.96 - 2.00 4.98 1.56 
9 5.35 - - 0.62 0.06 
12 - - - - -
Group 2; n=4 
1 4.68 1.49 4.33 5.13 2.98 
2 1.47 3.99 4.26 1.50 
4 - - 1.83 1.36 -0.28 
6 - - 1.08 - -
9 - - - 0.50 -
12 - - - - -
a- negative 
b- positive by qualitative bacteriology only 
Figure Legends 
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Figure 1. Serum antibody response of swine to S. choleraesuis 
LPS following challenge with S. choleraesuis (group 1), after 
natural exposure to a challenged group (group 2) or 
uninoculated controls (group 3). Reported values are the mean 
ELISA O.D.410 of either IgG (panel a) or IgM (panel b) isotype 
specific assays. 
Figure 2. Intestinal antibody response of swine to S. 
choleraesuis LPS following challenge with S. choleraesuis 
(group 1), after natural exposure to a challenged group (group 
2) or uninoculated controls (group 3). Reported values are 
the mean ELISA O.D.^io of either IgG (panel a), IgM (panel b) 
or IgA (panel c) isotype specific assays. 
Figure 3. Two-day in vitro blastogenic response to S. 
choleraesuis HE antigen of peripheral blood lymphocytes from 
swine following challenge with S. choleraesuis (group 1), 
after natural exposure to a challenged group (group 2) or 
uninoculated controls (group 3). 
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SUMMARY AND CONCLUSIONS 
These experiments demonstrate that a carrier state exists 
in swine infected with Salmonella choleraesuis. Results of 
these studies also indicate that regardless of route of 
infection, S. choleraesuis can persist in the tonsil, ICLN, 
ICJ and colon and can be excreted in feces of experimentally 
infected pigs for at least 12 weeks PI. Therefore, upon 
infection with 10® organisms and after resolution of initial 
clinical signs, the bacteria persist at relatively low numbers 
in clinically normal pigs establishing a carrier state. 
Infection of swine with S. choleraesuis in the present 
studies indicates that the tissue distribution was similar to 
that reported for S. typhimurium except that there was no 
predilection for S. choleraesuis to colonize the tonsil during 
acute disease. As the subclinical infection progresses the 
numbers of S. choleraesuis in the tonsil increase markedly. 
The organism may persist in the tonsil of intranasally 
infected pigs until 19 weeks post challenge. This suggests 
that the tonsils are a critical site for maintenance of S. 
choleraesuis in a herd. Although S. choleraesuis is often 
associated with pneumonia in swine, the pathogen was only 
recovered from the lung up to 6 weeks PI. This suggests that 
recovery from the lung, but not the tonsil, is indicative of 
acute disease, while recovery from the tonsil is more likely 
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to be indicative of a carrier animal. Additionally these data 
indicate that the tissues in which S. choleraesuis is most 
likely to be found at necropsy are the ICJ (68% recovery; 
groups combined) and ICLN (65% recovery; groups combined) 
suggesting that they should be included in slaughterhouse 
surveys and necropsies where S. choleraesuis is a potential 
isolate. 
However, these experiments also indicate that in 
comparison to experimental infection some differences were 
observed in naturally infected pigs. High concentrations of 
S. choleraesuis are observed in the tonsils for both naturally 
and experimentally infected pigs at 1 week PI. This suggests 
that either the tonsils became colonized due to a septicemia 
or that it is a primary site of invasion for 5. choleraesuis. 
Interestingly, tonsil populations are not observed in 
naturally infected pigs after 1 week PI. It is unclear 
whether tonsil populations during subclinical disease (>2 
weeks PI) is reserved as an artifact of high dose experimental 
infection or is triggered by an unknown factor not present in 
the group 2 pigs. The results presented here suggest that 
positive tonsil cultures may also indicate a very recent 
exposure to Salmonella spp. 
Pneumonia associated with S. choleraesuis infection is 
common. It is unclear whether this predilection for the lung 
is due solely to the pathogen, poor ventilation in large 
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confinement buildings or some combination of these and other 
factors. Experimental infection models have not provided good 
answers because positive lung samples have been regarded as an 
artifact of intranasal or per os inoculation. The data 
presented here indicates that the lung is a site of initial 
infection of S. choleraesuis in naturally exposed pigs. 
Salmonella choleraesuis was recovered from 6/8 lungs of the 
naturally infected pigs during the first two weeks of 
infection. The concentrations of S. choleraesuis in the lung 
remained at 1.5 logj.o CFU/g through 2 weeks PI in the naturally 
exposed group. 
The effect of route of inoculation was also studied. The 
intranasal route of inoculation results in more lesions and 
more severe clinical disease suggesting that S. choleraesuis 
is more virulent in swine following exposure by this route. 
In these studies the group infected intranasally have a 
greater magnitude and duration of fecal shedding when compared 
to the group challenged by gastric route resulting in more 
environmental contamination. In addition, a larger number of 
S. choleraesuis positive tissues are observed after intranasal 
inoculation for the first 6 weeks PI. These results suggest 
that respiratory exposure affects the pathogenesis and 
maintenance of S. choleraesuis in swine. 
There is a paucity of information regarding the magnitude 
and duration of fecal shedding of S. choleraesuis. These 
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studies have shown after a challenge of 10® CFU in 1 ml PBS 
marked clinical illness will occur. The magnitude of shedding 
after this dose was 10^ CFU/g which peaked between 72 hours 
and 3 weeks PI. Beyond 3 weeks PI S. choleraesuis was only 
detected in the feces in low numbers. However, shedding was 
detected regardless of route of inoculation throughout the 12 
week period. The T, N and R swab data and fecal cultures 
indicate that although these samples may be sufficient to 
detect S. choleraesuis within a herd, they are not effective 
in detection of individual carrier animals. However, since S. 
choleraesuis is mainly found in swine and swine operations, 
isolation from any sample suggests that an asymptomatic 
carrier is present, thereby increasing the likelihood for an 
outbreak within the herd. These data indicate that carrier 
animals shed low numbers of S. choleraesuis in feces and 
suggest that suspected shedders should be isolated from naive 
animals to control outbreaks involving S. choleraesuis in 
confinement units. 
There is a direct relationship between dose and shedding 
magnitude after a 10' or 10® dose of S. choleraesuis is given 
to pigs. Interestingly, regardless of dose, the pattern of 
shedding was similar between groups. Peak shedding was 
observed on day 5 for both groups and declined by 1 week PI. 
Regardless of dose, pigs demonstrated an increase in shedding 
at 5 weeks and 7 weeks, respectively. These data indicate 
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that regardless of dose, an intermittent paradigm of shedding 
occurs in carrier animals. These data also indicate that 
carrier swine may shed S. choleraesuis for at least 15 weeks 
PI as observed after administration of a 10® dose. 
Studies on the humoral immune response of S. choleraesuis 
carrier pigs have shown the development of a sequence of 
antibody isotype titers indicative of a classic humoral 
response to bacterial pathogens. The trends in isotype 
responses observed in the serum were also evident in 
intestinal immunoglobulin responses, regardless of route of 
inoculation. 
Both routes of inoculation are equally effective at 
stimulating peripheral blood B-cells. However the intranasal 
route is more effective, although slower, at activating 
peripheral blood T-cells. 
It has been proposed that adequate immunity to Salmonella 
spp. requires both humoral and cellular responses in the mouse 
model. This study indicates that swine can harbor S. 
choleraesuis for at least 12 weeks in the presence of a 
relatively high IgG to S. choleraesuis antigens. In general, 
a combined humoral, mucosal and cellular immune response to S. 
choleraesuis antigens was observed. The response coincided 
with the reduction in overall S. choleraesuis infection. This 
suggests that adequate immunity to S. choleraesuis in swine 
requires both humoral and cellular immunity. 
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The minimal dose required to produce a persistent 
infection of S. choleraesuis was also explored. Together 
these results demonstrate that experimental infection of swine 
with a dose of 10® CFU or higher will result in severe 
clinical disease and a long term carrier state. At moderate 
experimental doses, less than 10' but above 10^, inoculation 
will likely result in mild clinical disease and a short term 
carrier state of at least 9 weeks. A dose of less than 10^ 
will be cleared with no apparent shedding of the organism. 
These experiments also demonstrate a dose dependent 
response after experimental infection with regards to 
establishment of a carrier state, shedding and the immune 
response. The post mortem bacteriologic data did not indicate 
that a persistent infection occurred after challenge with a 
10^ dose of S. choleraesuis. 
A 10® dose .results in infection for at least 6 weeks PI 
and fecal shedding is detected until 9 weeks PI. However, S. 
choleraesuis could not be recovered from tissue or feces from 
these pigs after 9 weeks PI. A measurable antibody response 
is also observed in this group, as well as an antigen specific 
blastogenic response. These results indicate that 
experimental infection with 10® CFU of S. choleraesuis results 
in a carrier state with detectable shedding for at least 9 
weeks PI. 
A dose of 10' results in a long term carrier state. At 
188 
15 weeks PI the pigs in group 1 continued to shed S. 
choleraesuis and had multiple tissues positive for S. 
choleraesuis. In addition, we observed an average of 3 logs 
of S. choleraesuis/g of tonsil at 15 weeks PI. The carrier 
state obseirved in this group of pigs was present despite 
antibody titers and a measurable cellular response to S. 
choleraesuis antigens. This suggests that the immune system 
may be overwhelmed by such a large dose. 
At low doses (10^), S. choleraesuis is unable to 
stimulate a measurable antigen-specific lymphocyte response; 
however, normal mitogenic responses were observed. At 
moderate doses, between 10^ and lO', optimal antigen 
stimulation of lymphocytes occurs as well as normal mitogenic 
responses. At these moderate doses the immune response 
observed, here and in other studies is apparently successful 
at greatly reducing the pathogen load in the host. 
In contrast, at higher doses (10'), S. choleraesuis 
causes some degree of antigen-specific and non-specific 
suppression of lymphocyte activation. One reason for the 
increased shedding and level of infection observed in group 1 
may be the observed lymphocyte suppression. A long term 
carrier state occurs in group 1 despite a measurable humoral 
response and a suppressed cellular response. The observed 
immunosuppression is likely an important factor in the 
pathogenesis of S. choleraesuis in swine and our observations 
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suggest that it may play an important role in development of a 
carrier state. 
In contrast, it was also demonstrated that naive swine 
exposed to a population shedding as little as 2.61 log^o CFU/g 
of feces will begin shedding S. choleraesuis within 24 hours 
of exposure. In addition, severe clinical signs are observed 
in the naturally exposed group within 3 days of exposure to 
the experimentally infected population. This indicates that 
exposure to relatively low concentrations of S. choleraesuis 
may result in high morbidity and initiate a severe outbreak of 
swine paratyphoid within a relatively short period of time. 
This not only indicates the rapidity of S. choleraesuis 
transmission on the farm, but may also translate to rapid 
transmission and spread of Salmonella spp. during transport 
and time in lairage before slaughter. 
The data presented here indicate that only 1 of 4 
naturally infected pigs was positive at each of the 6, 9, and 
12 week necropsies suggesting two things. First, even after a 
severe clinical outbreak of swine paratyphoid, the numbers of 
S. choleraesuis carried in deep tissue and present in the 
environment is markedly reduced after natural exposure. A 
significant (P < 0.01) number of naive pigs are able to clear 
S. choleraesuis between 9 and 12 weeks PI, indicating that not 
all pigs will become long term carrier animals. Although no 
managsmant protocols were tested here, this data suggests that 
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good management practices can control and significantly reduce 
S. choleraesuis in swine herds. 
Secondly, these data suggest that a small fraction of 
carrier pigs are responsible for maintenance of this pathogen 
in the swine population. It has been shown that S. 
choleraesuis is a serotype that is rarely isolated in feeds or 
the environment implicating subclinical carrier swine in new 
outbreaks. It remains a mystery, however, as to the factors 
which induce carrier swine to shed levels necessary to 
initiate a new outbreak. 
Overall the tissues in which S. choleraesuis can most 
frequently be found in naturally infected pigs are the ICJ, 
ICLN, cec cont and cecum. During clinical disease (< 2 weeks 
PI) S. choleraesuis is isolated from many of the same tissues 
in naturally exposed pigs as is observed with field outbreaks 
and experimental infections. During the siabclinical carrier 
state, the tissues of predilection are the ICJ, ICLN, cec 
cont, colon, CLN and cecum in the naturally infected swine. 
This is similar to the tissue distribution which has been 
described after experimental infection of swine with either S. 
typhimurium or S, choleraesuis. The sole exception is that 
the tonsils were not positive in the subclinical naturally 
infected pigs. 
Interestingly, although the clinical signs of the 
naturally infected swine were similar to the experimentally 
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infected swine in severity and duration, peak shedding was at 
least 2 logs lower (1.5 logio CFU/g of feces for group 2 vs. 
3.6 logio CFU/g for group 1). This indicates that the high 
levels of shedding observed after experimental infection may 
not be indicative of shedding magnitude after natural 
infection. 
In this study, the naturally infected swine were exposed 
to a population shedding a maximum of 3.6 log^o CFU/g of feces 
with a maximum environmental load equal to 3.0 log^o CFU/g of 
feces. In comparison to experimental models, the naturally 
infected pigs would have needed to ingest between 250 g (10® 
CFU dose) and 25000 g (10* CFU dose) of feces each to manifest 
the severe clinical signs observed in this group. This amount 
of coprophagia is unlikely. 
Experimental infection models have shown that swine have 
a dose dependant immune response to S. choleraesuis. In the 
natural transmission study the humoral and cellular immune 
responses were similar between the naturally and 
experimentally infected pigs suggesting they received nearly 
the same dose or the organism was able to replicate to nearly 
the same levels in the host. Taken as a whole, these data 
indicate that during natural transmission the infectious dose 
of S. choleraesuis is much lower than experimental models have 
previously described. It may also be that pigs are exposed to 
a large dose of .5. choleraesuis by a mechanism other than 
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fecal oral transmission. The latter possibility would 
necessitate large populations of S. choleraesuis are excreted 
by infected swine by a route other than feces such as mucous 
or urine. However these high concentrations cannot be 
confirmed in the environmental samples. 
A more likely hypothesis is that there are factors 
involved in the natural transmission of S. choleraesuis which 
are not reproduced in experimental infection. Some of these 
factors may include the virulence of the S. choleraesuis 
following passage through the host which may allow lower 
infectious doses and may allow the organism to replicate to 
high levels in the host. Other factors involved in the 
transmission of S. choleraesuis may include the unknown affect 
of multiple inoculations with smaller doses and inoculation 
mechanisms not reproduced during experimental infections. 
Some combination of these and other factors is likely. 
As discussed previously the humoral, mucosal and cellular 
immune response observed for the naturally infected swine 
closely parallel that of the experimentally infected group. 
This indicates that in terms of immune parameters, the 
experimental infection may be an appropriate model for study 
of this response. In addition, this indicates that serum 
collected from experimentally infected swine provide a useful 
tool for the development of serologically based Salmonella 
detection tests. 
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In conclusion these studies have demonstrated that route 
of inoculation impacts on the carrier animal. However, 
regardless of route of inoculation, a carrier state persists 
for at least 12 weeks following challenge with 10® CFU S. 
choleraesuis. In addition, these data indicate that the 
magnitude of shedding and persistence of infection after S. 
choleraesuis infection is dose dependent. Low doses of S. 
choleraesuis can be easily cleared, moderate doses persist for 
at least 2 months, and high doses result in a long tezm 
carrier state. Regardless of dose, cellular and humoral 
immune activation occurs after inoculation. However, at high 
doses, S. choleraesuis causes signs of lymphocyte suppression, 
which may affect the ability of the immune system to eliminate 
the bacteria. These data provide an important model for 
future investigation of S. choleraesuis infection in swine. 
The model for S. choleraesuis transmission described in these 
studies provides a dramatic example of the difference between 
infection with Salmonella grown the laboratory versus the 
natural host and should be seen as a basis for design of 
future animal studies. 
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